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An external pilot study to test the feasibility of a
randomised controlled trial comparing eye muscle surgery
against active monitoring for childhood intermittent
exotropia [X(T)]
Michael Clarke,1,2* Vanessa Hogan,3 Deborah Buck,2 Jing Shen,4
Christine Powell,1 Chris Speed,3 Peter Tiffin,5 John Sloper,6
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Introduction: The evidence base for the treatment of strabismus (squint) is poor. Our main aim is to
improve this evidence base for the treatment of a common type of childhood squint {intermittent
exotropia, [X(T)]}. We conducted an external pilot study in order to inform the design and conduct of a
future full randomised controlled trial (RCT).
Methods: Children of between 6 months and 16 years with a recent diagnosis of X(T) were eligible for
recruitment. Participants were recruited from secondary care at the ophthalmology departments at four UK
NHS foundation trusts. Participants were randomised to either active monitoring or surgery. This report
describes the findings of the Pilot Rehearsal Trial and Qualitative Study, and assesses the success against
the objectives proposed.
Recruitment and retention: The experience gained during the Pilot Rehearsal Trial demonstrates the
ability to recruit and retain sites that are willing to randomise children to both trial arms, and for parents to
agree to randomisation of their children to such a study. One child declined the group allocation. A total
of 231 children were screened (expected 240), of whom 138 (60%) were eligible (expected 228: 95%)
and 49 (35% of eligible) children were recruited (expected 144: 63% of eligible). Strategies that improved
recruitment over the course of the trial are discussed, together with the reasons why fewer children were
eligible for recruitment than initially anticipated. Attrition was low. Outcome data were obtained for 47 of
49 randomised children.
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Trial processes and data collection: The Trial Management processes proved effective. There were high
levels of completion on all of the data collection forms. However, the feedback from the treatment
orthoptists revealed that some modifications should be made to the length and frequency of the health
service assessment and travel assessment questionnaires, thus reducing the burden on participants in the
main trial. Modifications to the wording of the questions also need to be made.
Monitoring of bias: Children who recruited to the trial were older and had more severe strabismus than
those children eligible but declining participation. Strategies to account for this in a full trial are proposed.
Reasons for participation or declining study: These were identified using qualitative interviews.
The principal reasons for declining entry into the study were strong preferences for and against
surgical treatment.
Harms: There were no serious unexpected adverse events. Two children had overcorrection of their X(T)
with reduction in binocular vision following surgery, which is in line with previous studies. No children
in the active monitoring arm developed a constant strabismus although two showed some reduction
in control.
Conclusions: The SamExo study has demonstrated that it is possible to recruit and retain participants to a
randomised trial of surgery compared with active monitoring for X(T). For longer-term full RCTs, in order to
maximise the generalisability of future studies, consideration needs to be given to planning more time and
clinic appointments to assess eligibility and to allow consideration of participation; the greater use of
research nurses for recruitment; and accommodating the strong preferences of some parents both for and
against surgical intervention.
Trial registration: Current Controlled Trials ISRCTN44114892.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 19, No. 39. See the NIHR Journals Library website
for further project information.
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Glossary
Abnormal retinal correspondence Subnormal binocular vision generated from images from eyes that
are misaligned.
Amblyopia (synonym: lazy eye) A developmental condition, in which there is dysfunction of the
processing of visual information, at a retinal and cerebral level, resulting from impaired visual input, to one
or both eyes, during a sensitive period of visual development. Common causes include strabismus and/or
refractive error, but more severe forms of amblyopia are seen when there is total absence of visual input
to one or both eyes, for example in cases of complete congenital cataract. Amblyopia never occurs in
isolation, rather it is the effect of another pathological process on the development of vision.
Binocular vision The ability to integrate the images from each eye to generate one percept with
information from each image. Generally considered to have three grades: simultaneous perception, fusion
and stereopsis, in which a three-dimensional image can be perceived.
Esotropia/esodeviation A convergent (inturning) misalignment of the eyes.
Exotropia/exodeviation A divergent (out-turning) misalignment of the eyes.
Ophthalmologist Clinician specialising in medical aspects of the diagnosis and treatment of eye and
visual disorders.
Optometrist/optician Clinician specialising in the correction of refractive error and eye examination.
May have an extended role covering the diagnosis and treatment of low-complexity eye disorders.
Orthoptist Paramedical professional specialising in the assessment and treatment of adults and children
with strabismus and amblyopia.
Orthotropia The condition of binocular alignment, i.e. no strabismus present.
Ptosis Drooping of upper eyelid.
Strabismus (synonym: squint) A condition in which the eyes are misaligned. Acquired strabismus from
late childhood leads to double vision (diplopia); strabismus with onset either from birth or early childhood
does not lead to double vision because cerebral plasticity allows central suppression of the image from
one eye when both eyes are open.
Suppression Blocking of the image of one eye from conscious perception.
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List of abbreviations
BLR bilateral lateral rectus recession
BTXA botulinum strain A
CASP Critical Appraisal Skills Programme
CI confidence interval
CRF case report form
ENR eligible not recruited
GCP Good Clinical Practice
GP general practitioner
HRQoL health-related quality of life
HSUQ Health Services Use Questionnaire
(Health Economics Questionnaire
Part A)
HTA Health Technology Assessment
HUI3 Health Utility Index Mark 3
ISF Investigator Site File
IXTQ Intermittent Exotropia
Questionnaire
NCS Newcastle Control Score
NCTU Newcastle Clinical Trials Unit
NIHR National Institute for Health
Research
PD prism dioptre
PI Principal Investigator
QoL quality of life
R&R recession/resection
RCT randomised controlled trial
REC Research Ethics Committee
RO research orthoptist
SamExo Surgery vs. Active Monitoring in
Intermittent Exotropia
TO treatment orthoptist
TSC Trial Steering Committee
TTQ Time and Travel Costs Questionnaire
(Health Economics Questionnaire
Part B)
UKCRN UK Clinical Research Network
VA visual acuity
X(T) intermittent exotropia
XT constant exotropia
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Plain English summary
S trabismus or squint is a common childhood condition in which the eyes are misaligned. Intermittentexotropia [or X(T)] is a common type of strabismus in which one eye sometimes turns outwards.
X(T) is commonly treated by surgery to the eye muscles. Our aim was to improve the treatment that
children receive by evaluating the risks and benefits of surgery for X(T) in a randomised study in which
some children, where it was safe to do so, had surgical treatment delayed. We could then see
whether or not some children got better without surgery.
Our study was designed to show whether or not parents, doctors and children would be willing for
children with X(T) to be randomised to early surgery or active monitoring, and whether or not they
continued with the study to the end. We also collected information about the effect of X(T), and the
treatment of it, on the child’s quality of life; information about whether or not the child’s X(T) was cured,
either spontaneously or by treatment; reasons why parents accepted or declined participation in the study;
the experience of parents and children who did participate; and costs to the UK NHS and the family.
Participants were patients at the ophthalmology departments of four NHS foundation trusts. In total,
231 children were screened, of whom 138 were eligible and 49 children were recruited.
The SamExo study (Surgery vs. Active Monitoring in Intermittent Exotropia) showed that it is possible to
recruit and retain participants to a feasibility trial of early surgery compared with active monitoring.
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Scientific summary
Background
Strabismus, also known as squint, is an ophthalmic condition in which the eyes are misaligned and
therefore look in different directions, i.e. one eye looks straight ahead while the other turns either
outwards (exotropia), inwards (esotropia), upwards (hypertropia) or downwards (hypotropia). It may be
constant (with loss of binocular function) or intermittent (with binocular function when the squint is not
present). Squint can occur in children or adults and may have functional, aesthetic and psychosocial
consequences. For example, teenagers and adults with squint have reported problems with self-esteem,
self-image and interpersonal relationships, have met ridicule at school or work, and may attempt to avoid
activities that bring attention to their condition or to develop strategies that conceal it. Similarly in young
children, squint has been linked to lower psychosocial functioning, poorer interpersonal relationships and
lower self-esteem. It has been shown that children as young as 5 years of age are significantly more likely
to have negative social reactions to peers with strabismus, and that teachers rate photographs of children
with strabismus more negatively than those with straight eyes.
Intermittent exotropia [X(T)] is one of the commonest types of childhood strabismus. In this condition,
one eye intermittently drifts outwards. It is possible for X(T) to develop into a constant squint [constant
exotropia (XT)], potentially leading to loss of stereo vision and/or the development of amblyopia (reduced
acuity in one eye caused by decreased quality visual input during the critical period of development).
Typically, X(T) is first spotted in early childhood by parents noticing that their child’s eye is wandering
outwards as they look at objects in the distance, or when they are very tired, inattentive or in
bright sunlight.
Conservative treatment options for X(T) include occlusion with eye patches or wearing glasses that
stimulate convergence. Eye muscle surgery can also be performed in order to realign the eyes. However,
many clinicians and parents opt for an active monitoring approach, i.e. they decide to wait and see
whether the squint resolves spontaneously or at the very least does not deteriorate. Long-term natural
history data are lacking, but there is some indication from observational work that X(T) surgery is more
successful than conservative treatment and active monitoring in improving control of the eyes.
However, the success of surgery is not guaranteed and comes with risks.
The lack of trial-based evidence means that the true effectiveness of treatment in ameliorating or curing
the condition is unknown. Moreover, even when surgery is the preferred course of action there is little
agreement on whether or not immediate surgery is more effective than delaying the operation for a
specified length of time or until a certain age.
The current investigators hope to conduct such a trial, if feasible. As the recruitment phase in any trial is
one of the most challenging, and given the potential recruitment barriers that are particularly inherent
in paediatric or surgical trials, we are first undertaking the SamExo (Surgery vs. Active Monitoring in
Intermittent Exotropia) pilot trial in order to assess feasibility and inform the design and conduct of a
full-scale trial.
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Objectives
The specific objectives of the SamExo pilot trial were to:
1. determine whether or not participating centres were likely to recruit a sufficient number of patients to
deliver a full trial
2. determine whether or not recruited patients would stay within their allocated groups and complete
follow-up in sufficient numbers to deliver the trial
3. identify reasons why parents accepted or declined participation in the trial
4. pilot the procedures involved in the trial including recruitment (giving information and obtaining
consent), randomisation, intervention (surgery), masking, outcome measurements, and web-based trial
management and data capture systems.
Methods
Design
The SamExo trial was a rehearsal pilot randomised controlled trial (RCT) to assess the feasibility of a full
RCT of the effectiveness of surgical treatment against active monitoring in X(T).
Setting
Four secondary ophthalmology care facilities at The Newcastle upon Tyne Hospitals UK NHS Foundation
Trust (co-ordinating site), Sunderland Eye Infirmary, Moorfields Eye Hospital and York NHS Trust, each of
which are large centres with specialist paediatric ophthalmology clinics.
Participants
Children aged between 6 months and 16 years, with suspected X(T), who were referred to the clinics from
community screening, general practice or other health-care professionals, and subsequently diagnosed
with X(T), as well as existing patients fulfilling the eligibility criteria.
Interventions
Clinic appointments
The assessments involved routine clinical measurements together with the evaluation of quality of life
(QoL) using the Intermittent Exotropia Questionnaire and collection of associated costs using a Health
Services Use Questionnaire, and a Time and Travel Costs Questionnaire. Children in the active monitoring
group were offered surgery if a constant strabismus appeared to be developing or parents requested
surgery and the responsible clinical team agreed that this was appropriate.
Eye muscle surgery
Surgery was performed by the local Principal Investigator, or delegated deputy, in accordance with agreed
surgical formulae tailored to the clinical characteristics of the strabismus and the usual practice of the
surgeon. Principles involved in the surgical treatment of children in the study were agreed as follows:
l general anaesthesia
l bilateral lateral rectus recession surgery to be performed for true distance exotropia
l unilateral recess/resect surgery to be performed for other types of exotropia
l standard sterile preparation of the operative site
l conjunctival incisions
l standard isolation and cleaning of muscle to be operated
l muscle secured with 6/0 VICRYL® (polyglactin 910) suture (Johnson & Johnson, New Brunswick, NJ, USA)
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l amount of recession/resection assessed on the basis of the maximum distance angle according to table,
modified according to standard practice of surgeon
l measurement of amount of muscle adjustment to be checked post placement of scleral sutures
l conjunctival incisions closed with VICRYL sutures
l topical anaesthetic and antibiotic drops given at end of procedure.
Surgical technique was carefully recorded and monitored during the pilot with a view to standardising
surgical technique, as far as it was possible to do so.
Outcome measures
The key outcomes of this pilot study were:
l data on the variability of the primary and secondary outcome measures
l rates of participant recruitment and randomisation
l nature and extent of participation bias
l rates of crossover and retention of recruited participants
l nature and extent of biases arising from crossover or loss to follow-up.
Secondary outcomes include age-specific QoL assessments, median scores of control of exotropia assessed
by parental report and clinical components of the Newcastle Control Score (NCS) and the Mayo Score and
rates of amblyopia. Economic outcomes were restricted to the completion rates of data collection tools.
No formal economic analysis was conducted.
Results
All sites that began recruitment of patients were retained throughout the Pilot Rehearsal Trial and all have
expressed an interest in continuing with a full trial.
Patient retention rate was also high, with 47 of 49 (96%) of recruited participants attending the final
appointment, scheduled at 9 months post randomisation.
In total, 231 children were screened (expected 240), 138 (60%) of whom were eligible (expected 228:
95%) and 49 (35% of eligible) children were recruited (expected 144: 64% of eligible). Many more
children than predicted did not fulfil the eligibility criteria for the study (10/240 predicted vs. 93/231
observed). Reasons for non-eligibility were determined for 87 of 93 (94%). The most common reason for
children not to meet the eligibility criteria was that their strabismus was not sufficiently severe.
Consent was obtained from 56 of 89 (63%) ‘eligible not recruited’ (ENR) patients to record baseline and
9-month follow-up clinical data. The demographic and clinical characteristics of the ENR group were
compared with those who agreed participation in SamExo. Those who agreed to take part had poorer
control of their exotropia (as assessed by the NCS) than those who declined; although statistically
significant, this difference is unlikely to be clinically significant.
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Conclusions
We have demonstrated that it is possible to recruit and retain participants to a trial of surgery compared
with active monitoring for X(T); however, despite screening the anticipated number of children with X(T),
recruitment levels fell short of those predicted. This can be attributed to two issues.
First, the proportion of children eligible for inclusion was much lower than anticipated. This was primarily
due to the proportion of screened children who did not have a severe enough strabismus for inclusion.
Tightening the inclusion criteria to conform with current clinical practice would, while reducing the number
of potential recruits overall, increase the proportion who were eligible.
Second, given the expressed views of many parents of children who were eligible for inclusion regarding
their preferences – both for and against surgical treatment for X(T) – the development of a formal RCT
should include consideration of a preference arm, which would increase the participation of
eligible children.
Although not powered to assess the effectiveness of surgery as an intervention, the clinical outcomes do
indicate agreement with previous research which suggests that, over a short follow-up period, the majority
of patients who are actively monitored do not significantly improve or deteriorate, whereas most patients
who undergo surgery have, in the short term, improved alignment, albeit with a rate of between 10% and
20% of overcorrection with a deterioration in stereoacuity.
Trial registration
This trial is registered as ISRCTN44114892.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Background
Strabismus
Strabismus (sometimes referred to as ‘squint’) is a condition in which the eyes are misaligned, either
constantly or intermittently.1 Intermittent strabismus may progress to constant strabismus. Strabismus may
have both socioeconomic and functional consequences for the affected individual.2–4
The appearance of ocular misalignment may result in discrimination – in both interpersonal relations and
employment – in adults,5 and in social exclusion and bullying in children.6
The functional consequences of strabismus include impairment of three-dimensional (binocular) vision4 and
amblyopia (lazy eye),7 which is impairment of visual acuity (VA) in one eye due to the effect, in this case,
of ocular misalignment on visual development.
In 2011–12 there were 584,916 hospital appointments for children, between the ages of 0 and 9 years, in
children’s eye outpatient departments, including orthoptic departments, in the UK (13% of total UK NHS
outpatient appointments for this age group).8 Ninety per cent of this workload is thought to relate to the
management of strabismus and amblyopia.9 In total, 6205 extraocular muscle surgeries were performed on
children aged between 0 and 14 years during the same period.
The evidence base for the treatment of strabismus is poor, and this results in significant variation in the use
of health-care resources, which is not easily explained and may not be clinically justified.10
Intermittent exotropia
Intermittent exotropia [X(T)] is a common type of strabismus in which the eyes are intermittently in a
divergent misalignment.11,12
Intermittent exotropia is the commonest form of divergent strabismus in childhood13,14 and has been
associated with later mental illness.15 The usual age at onset of X(T) is between 12 and 24 months.11,13
Three-dimensional vision for near viewing is usually within the age-related normal range but may
deteriorate if the strabismus progresses from an intermittent to a constant misalignment.16 X(T) is
particularly common in Eastern Asia but is thought to be increasing in prevalence worldwide.17
The NHS tariff rate for strabismus surgery is £800, and, together with around 100,000 clinic visits annually
for review of patients with X(T) (at a tariff cost of £120 per new patient and £60 per review: estimated
average new–review ratio of 1 : 8), the total cost to the NHS alone is almost £7.5M annually. With the
inclusion of societal and family costs, the management of X(T) is costly.
The underlying cause of X(T) is unknown. The condition is diagnosed on the basis of a parental history of
an intermittent ocular misalignment, which may be accompanied by closure of one eye, and on the
demonstration of the potential of the eyes to adopt a divergent misalignment when binocular viewing is
disrupted by covering one eye (cover test).1
The frequency of the observed misalignment, or eye closure, and the ease with which the eyes realign
following a cover test, is referred to as the control of the strabismus, and is used as clinical indicators of
the severity of the condition.18,19 Other measures of severity include the size of the ocular misalignment at
near and distance viewing, and stereoacuity (a measure of three-dimensional vision).20
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Treatment is sought and recommended on the basis of concern about the appearance of the misalignment
and the potential for disruption of normal visual development.21
Treatment may be surgical (eye muscle surgery or botulinum toxin injection);22 non-surgical (glasses,
patching, prisms, exercises);23 or a combination of the two.24,25
Eye muscle surgery for X(T) aims to adjust the tension in the extraocular muscles such that the eyes are
placed in a less divergent alignment. This can be achieved by weakening one or both lateral rectus
muscles, either alone, or in combination with tightening of one medial rectus muscle.
Around 10–20% of children develop an intermittent or constant convergent strabismus following surgery
for X(T), with some requiring further corrective procedures.20,25,26
There are few data on the efficacy of non-surgical treatments for X(T) but, in general, they appear to be
significantly less effective than eye muscle surgery.24
A recently updated Cochrane review,27 specifically addressing the treatment of X(T), identified only one
trial that was eligible for inclusion. This trial showed that unilateral surgery was more effective than
bilateral surgery for correcting the basic type of X(T). No trials were identified comparing eye muscle
surgery with watchful waiting or active monitoring.
The authors of the review concluded:
The available literature consists mainly of retrospective case reviews, which are difficult to reliably
interpret and analyse. The one randomised trial included found unilateral surgery more effective than
bilateral surgery for basic intermittent exotropia. However, across all identified studies, measures of
severity and thus criteria for intervention are poorly validated, and there appear to be no reliable
natural history data. There is therefore a pressing need for improved measures of severity, a better
understanding of the natural history and carefully planned clinical trials of treatment to improve the
evidence base for the management of this condition.
Another recent paper28 has commented:
To address controversies and improve the evidence base regarding surgical intervention of this
condition, randomized controlled trials are needed and justified because the results indicate that it
would be relatively safe to randomly allocate patients to groups who could receive differing treatments
so as to determine optimum management strategies.
Evidence from randomised controlled trials of the treatment of X(T) is increasing. A randomised controlled
trial assessing the relative benefits of different forms of eye muscle surgery is in progress29 and a trial
comparing patching (occlusion) to observation has just been published.30 Although the latter study
provides some natural history data neither study addresses the utility of surgical treatment of X(T) per se.
The feasibility of randomised controlled trials (RCTs) of strabismus treatment has been questioned.
A Health Technology Assessment (HTA)-sponsored systematic review of the clinical effectiveness and
cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of
4–5 years31 commented, ‘RCTs into the efficacy, effectiveness and efficiency of strabismus treatment are
unlikely to be feasible. Ethical considerations in study design prevent complete abstention of treatment,
and decisions regarding treatment are often overridden by clinical need’.
We disagree with this statement, and do not see how the subject can make progress in establishing a
robust evidence base without such studies.
INTRODUCTION
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A previous trial of deferred surgery for a different form of strabismus,32,33 infantile esotropia, demonstrates
the potential for recruitment into RCTs of strabismus while highlighting some of the challenges that are
inherent in this type of research.34
We therefore proposed a study to determine the feasibility of a RCT of surgery compared with active
monitoring for X(T).
Objectives
The specific objectives of the SamExo study (Surgery vs. Active Monitoring in Intermittent Exotropia),
as stated in the original project description, were to:
1. determine whether or not participating centres are likely to recruit a sufficient number of patients to
deliver the trial
2. determine whether or not recruited patients will stay within their allocated groups and complete
follow-up in sufficient numbers to deliver the trial
3. develop a web-based trial management system to centralise and automate trial processes such as
invitation, logging of replies, scheduling of appointments, confirmation of eligibility, randomisation and
printing of letters
4. pilot the procedures involved in the trial, including recruitment (giving information and obtaining
consent), randomisation, intervention (surgery), masking, and baseline and follow-up data collection
5. monitor potential bias by comparing the demographic and clinical status of patients retained with any
withdrawing from the trial, and by comparing those who consent with those eligible but refusing
to participate
6. identify through questionnaires and qualitative interviews, where possible, reasons why parents decline
permission to participate
7. prepare a detailed protocol and application for funding for such a RCT (if findings from the pilot study
indicate that a full-scale RCT is feasible).
Systematic review
The opportunity to apply for further funding for an associated project was offered once the trial was
under way. Given the difficulty in synthesising the literature on X(T), and the lack of RCT data highlighted
in the Cochrane review, a systematic review of non-randomised studies was proposed and funded,
and the output of this work is included in this report.
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Chapter 2 Systematic review
Background
Intermittent exotropia [X(T)] is a common form of childhood strabismus (squint) affecting approximately
two out of every 100 children before the age of 3 years.35 This particular ocular misalignment is
characterised by an outwards deviation of the eye, which is not constant but is usually present initially on
distance fixation or when the child is tired.20 The natural history of X(T) is poorly understood: the ocular
misalignment may worsen or deteriorate into constant exotropia, which adversely affects stereo vision;
conversely the misalignment may resolve over time.36 X(T) is also of concern for psychosocial reasons, as
the cosmetic appearance might cause the child to develop social or psychological problems,2 which can
impact into adult life, with effects on self-image, work and personal relationships.37
A range of both conservative and surgical treatment options are available and include observation
(watchful waiting), orthoptic exercises/vision therapy, occlusion therapy (patching), minus lens therapy
(glasses) and surgery.38 However, surgery is associated with possible adverse effects, including a risk of
overcorrection, which may also adversely impact on stereoacuity. Evidence for the comparative
effectiveness of treatment options is limited by the absence of RCT data,27 but there is a much larger
literature of observational studies for the various interventions. As a consequence of the absence of robust
and reliable effectiveness data on treatment options, and of uncertainty about the natural history of the
condition, wide service variation exists (both nationally and internationally) in management of
the condition.
Aim
The main aim of the review was to determine the effectiveness of surgical and non-surgical approaches as
a means for managing X(T) in childhood. Secondary objectives were to (1) understand the circumstances
under which particular interventions are most effective; (2) determine adverse effects associated with
particular interventions; and (3) better understand the natural history of X(T).
Methods
The review was conducted following best practice guidelines for the design, conduct and reporting of
systematic reviews.39–41
Criteria for considering studies for this review
Participants
Studies that involved child participants aged up to 18 years were included. Studies including mixed
populations (i.e. both adults and children) were eligible if they reported the results for children separately.
To satisfy our inclusion criteria, the diagnosis was one of intermittent disease, rather than constant
exotropia, and the type was either divergence excess or basic-type exotropia. Convergence insufficiency-
type exotropia (misalignment primarily at near fixation) was excluded.
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Interventions
A range of both surgical and non-surgical interventions were examined. As well as corrective surgery,
we reviewed studies reporting on non-surgical interventions, including minus lenses, prisms, convergence
exercises, occlusion therapy, onabotulinumtoxinA (BOTOX®, Allergan) injections and watchful waiting
(Box 1). We included studies that made a single comparison (e.g. unilateral vs. bilateral surgery) as well as
studies reporting on the effectiveness of multiple therapies (e.g. surgery vs. BOTOX, vs. minus lenses
vs. watchful waiting).
BOX 1 Description of interventions
Surgical interventions
Surgery aims to prevent deterioration to constant exotropia, improve distance stereoacuity and improve
appearance.20 The following procedures are commonly offered:
Bilateral lateral rectus recession
This surgical technique involves weakening of the lateral rectus muscles that control eye movement. Bilateral
surgery is undertaken on both eyes, whereas unilateral lateral rectus recession involves one eye only.
Recession/resection
Horizontal rectus surgery (unilateral lateral rectus recession combined with medial rectus resection) is
undertaken on the dominant or non-dominant eye to shift the muscular insertion points and alter the balance
of forces on the globe.42
Non-surgical interventions
Botulinum toxin
The neurotoxin is used both diagnostically and therapeutically in the management of strabismus.
Therapeutically it is used to temporarily paralyse the lateral rectus muscle leading to altered ocular alignment,
which returns over time.43,44
Overminus lenses
Overcorrecting minus lenses aim to stimulate convergence of the eyes through the extra effort required
to focus.23
Occlusion
Occlusion or patching aims to prevent development of abnormal adaptation to eyes being diverged.42
Orthoptic exercises
The objective of orthoptic exercises is to increase fusion, eliminate suppression and improve control in order to
reduce the time during which the deviation is manifest.45
Observation
Given that the natural history of X(T) is unclear, observation or watchful waiting is another conservative option
for management of X(T), particularly in cases of small-angle X(T).42
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Study designs
Given the paucity of high-level evidence in this area, we included RCTs, quasiexperimental studies and
comparative observational studies (both prospective and retrospective studies, each with a comparator
group). [Based on the Cochrane definition of cohort study as ‘A non-randomised (observational) study in
which a defined group of people (the cohort) is followed over time. The outcomes of people in subsets
of this cohort who received two or more different interventions are then compared’. This includes
‘routine database followed over time’ prospectively or retrospectively (source: http://bmg.cochrane.org/
research-projectscochrane-risk-bias-tool). Accessed 17 December 2014] Case series (defined as chart
reviews without a comparison group), qualitative studies and non-empirical, opinion pieces were excluded.
Only studies with a follow-up period of at least 6 months were included.
Outcomes
Data on the following outcomes were extracted: angle of deviation, stereoacuity and control. We also
sought to record quality of life (QoL) and patient-derived outcomes (e.g. acceptability and adherence),
where possible, as well as data on adverse effects. The eligibility criteria used in the review are shown
in Box 2.
BOX 2 Summary of review eligibility criteria
Inclusion criteria
Participants up to and including the age of 18 years. Where there was a mixed population of adults and
children, a study was eligible only if it reported outcomes for children separately.
Divergence excess type [where the deviation is greater (by at least 10 PD at distance than at near], simulated
divergence excess type [the deviation is initially greater at distance but after occlusion there is little difference
between near and distance measurements (within 10 PD)] or basic type (the deviation is the same at both
distance and near) X(T).
Follow-up for at least 6 months.
RCT, quasiexperimental or cohort study with a comparison group.
Exclusion criteria
Population aged > 18 years (or data not reported for children separately from adults).
Data unavailable for X(T) separately. In instances when the population included X(T) combined with constant
exotropia (or other forms of strabismus), a study was eligible only if disaggregated data were reported for X(T).
Participants with convergence insufficiency type X(T) [the deviation is greater (by at least 10 PD) at near than at
distance]. Studies were excluded if they reported outcomes for divergence excess and basic type combined with
convergence insufficiency.
Studies with follow-up of < 6 months.
PD, prism dioptres.
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Search strategy
We conducted systematic searches using the following databases (abbreviations, host sites and dates
searched given in parentheses):
l MEDLINE (Ovid, 1946 to October week 3 2012)
l EMBASE (Ovid, 1980 to October week 42 2012)
l Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library via Wiley, issue 7 of
12 August 2012)
l UK Clinical Research Network Study Portfolio (UKCRN, August 2012)
l Cochrane Database of Systematic Reviews (CDSR, The Cochrane Library via Wiley, issue 7 of
12 August 2012)
l Database of Abstracts of Reviews of Effects (DARE, The Cochrane Library via Wiley, issue 7 of
12 August 2012)
l Health Technology Assessment Database (HTA, The Cochrane Library via Wiley, issue 7 of
12 August 2012)
l Cumulative Index to Nursing and Allied Health Literature (CINAHL, Ovid, 1981 to August 2012)
l PsycINFO (Ovid, 1967 to August week 2 2012)
l Science Citation Index (Web of Knowledge, 1970 to August 2012)
l Conference Proceedings Citation Index (Web of Knowledge, 1990 to August 2012)
l Latin American and Caribbean Literature on Health Sciences (LILACS, Virtual Health Library; 1982 to
September 2012).
Initially a search was conducted which combined synonyms for exotropia with synonyms for
under-18-year-olds. Subsequently, we decided to remove the age-related part of the search to capture
studies in paediatric journals, which are less likely to specify in the title and abstract that they concern
children, and the search was rerun in those databases in which age limits had been used. The search
strategy was designed on MEDLINE (Ovid) and translated to other databases. Database-specific thesaurus
terms [such as medical subject headings (MeSH)] were used as appropriate for each database.
For an example search strategy designed for MEDLINE please see Appendix 1. We supplemented the
electronic searches by hand-searching the bibliographies of all included studies for any additional related
references, as well as searching the following key organisational websites:
l Association for Research in Vision and Ophthalmology: www.arvo.org/ – searched meeting abstracts
l American Association for Pediatric Ophthalmology and Strabismus: www.aapos.org/
l Royal College of Ophthalmologists: www.rcophth.ac.uk/ – searched 1st & 2nd World Congress of
Paediatric Ophthalmology & Strabismus
l European Paediatric Ophthalmological Society: www.epos-focus.org/ – searched meetings
l European Strabismological Association: www.esa-strabismology.com/
l American Society of Certified Orthoptists: www.orthoptics.org/ – searched American Orthoptics Journal
l American Academy of Ophthalmology: www.aao.org/
l British Orthoptic Society: www.orthoptics.org.uk/.
We contacted key experts in the field for information about unpublished or in-progress studies and used
relevant e-mail lists to issue a request for information about unpublished or ongoing studies that fit the
eligibility criteria. We also manually searched the table of contents of key journals (including Journal of
Vision; Investigative Ophthalmology and Visual Science) for the past 12 months to identify any papers
not yet indexed. For two journals (British Orthoptic Journal and Australian Orthoptic Journal) that are not
indexed on PubMed, we hand-searched the table of contents for the past 5 years.
References were managed using EndNote reference management software, version X6 (Thomson Reuters,
CA, USA). Reasons for exclusion of studies at full paper sifting stage were recorded. Given the
epidemiology of X(T)27 we did not exclude studies on the basis of language, country or publication date.
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Selection of studies
Two reviewers (FB and KJ) read the papers’ abstracts independently to consider whether or not the study met
the eligibility criteria. Any studies deemed to be potentially relevant by either of the reviewers were sourced in
full text and obtained for the second stage of the screening/sifting process. One reviewer (KJ) screened the
full papers to exclude any obviously non-relevant papers (specifically letters, commentaries, reviews and
qualitative studies); two reviewers (FB and KJ) then applied the eligibility criteria independently to determine
inclusion in the review. If there was any disagreement regarding the eligibility of any of the research papers,
the two reviewers met to discuss the ambiguous studies in order to come to a definitive decision on whether
or not inclusion was warranted. In the situation of non-agreement, a third reviewer (MC or RT) provided input.
Strategy for dealing with foreign-language papers
To eliminate the prospect of language bias we used Google Translate to translate abstracts in order to apply
our eligibility criteria. Where we remained unsure we recruited bilingual and multilingual postgraduate
students and staff from our institution to support screening of foreign-language titles and abstracts.
The process of data extraction of eligible foreign-language papers was then undertaken in collaboration with
our bilingual and multilingual volunteers. For two of the papers (written in simplified Chinese) this was
repeated with a second volunteer to enhance reliability of the process. This method enabled us to data extract
and critically appraise the studies without having to translate the papers verbatim.
Data extraction
Dual independent data extraction was undertaken. To understand the conditions under which
interventions are most successful, details around how the intervention was delivered (e.g. for
surgical interventions we noted whether or not the aim of surgery was overcorrection), duration of
treatment, length of follow-up, and completeness of follow-up, together with any additional contextual
data, were recorded on the data extraction form (see Appendix 2). Likewise, detailed information on the
study population was extracted to identify what intervention works for whom and at what time point
(to include age, time after diagnosis and severity of misalignment). When data were missing or required
clarification, we contacted the study authors for further details. We also contacted the study authors of
any conference abstracts meeting the eligibility criteria.
Quality assessment
Each study was appraised for quality simultaneously alongside the data extraction process. We used the
Cochrane Risk of Bias tool for RCTs and for non-randomised studies we used a tool based on the Critical
Appraisal Skills Programme (CASP46) instrument for cohort studies, which includes assessment of both
internal and external validity with questions relating to selection bias, study design, confounding, data
collection methods, dropout and intervention integrity (see Appendix 3). We neither calculated a quality
score nor did we exclude studies on the basis of quality. Any differences in assessment were resolved
through discussion between reviewers (KJ and FB) and, if necessary, with other members of the study team
(MC and RT).
Data synthesis
We used the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidance and
flow chart to support reporting41 (Figure 1). Studies can be pooled only if a number of studies are identified
reporting the same primary outcome measure and there is sufficient homogeneity in terms of study design,
intervention type and population. We were unable to synthesise any data quantitatively in the form of a
meta-analysis due to high levels of study heterogeneity. Differences in study design, population,
intervention and outcome measures precluded meta-analysis. In particular, there was a great deal of
divergence in defining what constitutes a positive outcome. For example, change in angle of deviation
versus with stereoacuity versus degree of control and how success was defined [e.g. deviation
of > 20 prism dioptres (PD)] compared with deviation of < 10 PD, which is clearly likely to impact on
comparable effectiveness between studies) and at what time point measurements were undertaken.
Equally, there were differences in the study populations, for example some studies included only divergence
excess type, whereas others grouped basic, true and simulated divergence excess types together.
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Because heterogeneity between studies precluded meta-analysis, we performed a narrative synthesis and
report study findings separately by intervention type. In the narrative synthesis, we describe the main
characteristics of the studies included, along with information about study quality and estimates of effect
with relevant statistics. To avoid the introduction of bias into the narrative synthesis we have aimed to
report the findings of each study judiciously and have made efforts to avoid inappropriate emphasis on any
one particular study or author.
Findings
Description of studies
Electronic searches of 12 databases produced 7136 hits, which was reduced to 1902 after removal of
duplicates. An additional 31 articles were retrieved through hand-searches, citation follow-up, discussion
lists and key expert contact. On the basis of the abstract, these appeared to meet the eligibility criteria but
all were excluded after review of the full text. A total of 314 papers were retrieved for full paper analysis
but only 11 satisfied our eligibility criteria (see Appendix 4 for reasons for exclusion).20,42,47–55 A further four
conference abstracts were identified as potentially eligible on the basis of abstract alone,56–59 we wrote to
the study authors for more information but received a response from the authors of only one of the papers
stating that there was no comparison group.
Of the 11 studies that satisfied the inclusion criteria (Table 1), seven examined only surgical
interventions,47,49–53,55 whereas four examined either surgery compared with non-surgical interventions or
Records identified through
database searching
(n = 7136)
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Records after duplicates removed
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Records screened
(n = 1933) 
Records excluded
(n = 1619) 
Full-text articles assessed
for eligibility
(n = 314) 
Full-text articles excluded,
with reasons
(n = 303)
Studies included
(n = 11)
FIGURE 1 Flow chart of search process (based on PRISMA guidelines).
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non-surgical interventions alone.20,42,48,54 Non-surgical interventions included glasses, occlusion therapy,
orthoptic exercises, prisms, BOTOX treatment, binocular vision therapy or observation only. Only 2 of
the 11 studies were RCTs: one compared bilateral and unilateral surgery47 and the other examined the
effectiveness of binocular vision training after surgery compared with no training.48 The remaining nine
studies were non-randomised observational studies involving a comparator group; the majority were
retrospective with only two prospective studies.20,54
Three of the included studies were non-English-language papers written in Chinese (simplified)48,54 and
French.55 Screening of titles and abstracts identified 122 foreign-language papers, of which 37 were
reviewed at full-text stage. We collaborated with seven foreign language speakers [Chinese (two native
speakers), French, German, Italian, Polish, Russian] to support the translation, data extraction and critical
appraisal processes.
Characteristics of setting and participants
Four studies were conducted in Europe, the USA or Australia, whereas seven were conducted in Asian
countries, which might be reflective of the epidemiology of X(T), specifically the observation that X(T) is
more frequent in Asian populations and latitudes with greater exposure to sunlight.27 Three studies were
conducted in South Korea,50–52 two in China,48,54 one in the USA47 and one each in Australia,42 Belgium,55
Japan,53 Singapore49 and the UK.20
There was some heterogeneity between studies in terms of the study population examined.
Three studies20,49,51 included basic and divergence excess (simulated or true) types of X(T), whereas four
studies47,50,52,55 included basic type only and four studies42,48,53,54 did not report on the type of X(T)
examined. Only one study20 stated that their sample was recruited from multiple centres; the remainder
were single-centre studies.
Risk of bias in included studies
Randomised controlled trials
Two RCTs47,48 met our eligibility criteria: both were judged to have a high or unclear risk of bias in
most areas according to the Cochrane risk of bias tool (Table 2). Both trials were unclear in their reporting
of randomisation and allocation concealment procedures. One trial47 was judged to have a high risk
of selection bias because the three groups were not assigned simultaneously and there were some
inconsistencies in reporting of exclusion criteria (patients were also being recruited for two different trials
concurrently). The methods in the other RCT48 were poorly reported, specifically with respect to techniques
used for randomisation and allocation concealment. Detection bias was a concern in both trials, specifically
around masking of outcome assessment. Where details of the intervention were unclear48 (i.e. duration of
binocular vision training) we wrote to the study authors for further information but received no response.
Both trials were judged to have low risk of bias with respect to attrition bias because one52 reported
TABLE 2 Quality appraisal of RCTs (Cochrane risk of bias tool)
Quality criteria Kushner 199847 Qiu 201048
Sequence generation U U
Allocation concealment U U
Blinding N U
Incomplete outcome data Y Y
Selective outcome reporting N N
Other sources of bias N N
N, not addressed; U, unclear or not reported; Y, adequately addressed.
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reasons for exclusions (albeit with uncertainty about the inclusion/exclusion of the patients from the other
trial), and the other reported data for all participants at 1 year.48
Non-randomised studies
Of the nine cohort studies with comparison groups,20,42,49–55 two of the studies20,54 were prospective
(Table 3). A strength of the inception cohort study20 was that it recruited from multiple centres with a final
sample size of 371 and a loss to follow-up of only 24%, whereas the other prospective cohort54 was a
single-centre study and had a smaller sample (n= 60) and short follow-up period (6 months only), although
it should be noted that there was no loss to follow-up in this study. Neither of the prospective studies used
matched comparison groups. The remaining seven cohort studies42,49–53,55 were retrospective in design.
Of the nine non-randomised studies included,20,42,49–55 three used consecutive recruitment,42,50,52 one study20
identified cases prospectively from multiple cases according to well-defined inclusion criteria, and three
studies49,51,53 identified cases retrospectively using well-defined inclusion criteria. In the remaining
two studies54,55 details of how patients were recruited is either poorly described or unclear. In at least five
of the studies there is a possibility of selection bias associated with determining which patient received
which procedure, as many of the studies state that the choice of intervention was at the ophthalmologist’s
or parents’ discretion.20,42,49,50,54 With regard to the possibility of bias incorporated during exposure to the
intervention, we assessed whether the interventions were carried out according to guidelines or a
standardised protocol. Six studies42,50–53,55 included reference to a standardised protocol or guidelines to
determine the amount of surgery performed. In one study it was stated that the amount of surgery was
at the discretion of the operating surgeon,49 although this was unclear in two other studies.20,54 Surgery was
performed by three surgeons in one study,49 in six studies42,47,50–52,55 all procedures were performed by one
surgeon, and in the remaining three studies48,53,54 details of who performed the surgery were not reported.
Differences in outcome assessment were considerable across the studies with a range of outcome
measures being reported including motor alignment (angle of deviation), sensory function (stereopsis),
control or a combination of the above. Of those studies reporting motor alignment as the primary
outcome, one reported median change in deviation20 and the remainder42,47,49–55 reported success or
improvement rates. However, ‘success’ or ‘improvement’ was variously defined so (leaving aside
differences in study design, population and follow-up point at which outcomes were assessed) the studies
were not suitable for pooling in a meta-synthesis. The diversity in definitions of success used is an
important issue here, with some studies conceptualising a successful outcome as anything within
20 PD of orthotropia,53,55 whereas other authors operationalised a much stricter definition (e.g. ≤ 5 PD
esophoria/-tropia to ≤ 10 PD exophoria/-tropia,47,50 and various definitions in between (e.g. deviation within
± 8 PD52 or deviation within ± 10 PD42,49,54). In terms of assessment of outcome measures, only one study50
reported carrying out measurements of the angle of deviation on three different occasions; in the
remaining studies20,42,49,51–55 minimal detail was reported with regard to when outcomes were measured
and how many times measurements were taken.
In two studies there were sparse42 or no data53 reported to assess the possibility of significant baseline
differences between the intervention and control groups in terms of age and severity of X(T) at
baseline, both of which are important confounding factors. Four studies51,52,54,55 reported no statistically
significant differences between the intervention and comparison groups at study outset. However, two
studies49,50 reported significant differences between the two groups at baseline, the former in initial angle
of deviation and the latter in age, but no adjustments were made for these differences in their analyses.
Surgical interventions (one surgical technique versus another)
Of the seven studies examining the effectiveness of surgery, six compared symmetric with asymmetric
surgery [bilateral lateral rectus recession (BLR) vs. unilateral recess resect].47,49–51,53,55 One study52 compared
effectiveness between augmented and non-augmented forms of symmetric surgery. Only one of the
surgical intervention studies47 was described as a RCT, the remainder were retrospective cohort studies
with a comparison group.
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Bilateral lateral rectus recession compared with unilateral recess resect
One RCT47 and five retrospective cohort studies49–51,53,55 reported on these surgical techniques. The RCT47
was conducted in children aged 3–18 years with basic type X(T), and compared unilateral recession/
resection (R&R) (n= 17) with BLR (n= 19). A satisfactory outcome, measured 12 months after surgery, was
defined as between 10 PD of exophoria and 5 PD of esophoria; stereoacuity was not assessed. The study47
reported a significantly higher proportion (p< 0.02) of patients with a satisfactory outcome in those
receiving R&R procedures (82%,14/17) than in those receiving BLR (52%, 10/19) at least 12 months after
surgery (range 12–15 months). The authors also compared their results to a non-randomised ‘control’ group
of children with simulated distance exotropia (n= 68) who all received BLR surgery. Successful outcomes
were observed in 81% of patients in the control group (55/68); overcorrection and undercorrection
rates were 4% (3/68) and 15% (10/68) respectively. The results were significantly different to the patients
with basic X(T) receiving BLR (p< 0.05) but similar to those receiving R&R. The study, however, was limited
in several respects. First, there was a dearth of information about the randomisation procedures used,
making it difficult to assess whether or not the method used to generate the allocation sequence would
produce comparable groups and also whether or not the allocation sequence was concealed.
Neither participant nor clinician was blinded to the intervention received. Likewise, outcome assessment
was unblinded, with the clinician who performed surgery also measuring outcomes at 12 months (little
detail is reported on how outcomes were measured, i.e. exact time point and number of measurements).
It is noteworthy that the author excluded patients for whom he knew that, at the time of surgery, the
referring physician would be conducting follow-up assessment. In addition patients, were excluded because
they were enrolled in another in-progress RCT led by the author. The exclusion criteria used raise questions
about the fidelity of the randomisation processes and actual study design used, and the possibility of selective
reporting. The absence of clear and well-defined criteria for considering a patient for surgery (e.g. size of
deviation, control of deviation) also introduces possible bias to the study findings. Finally, the sample size
was also small (total n= 36) and the follow-up period may be insufficient to allow generalisability.
A retrospective cohort study49 (n= 118) of children aged < 16 years with either divergence excess or basic
type X(T) compared the effectiveness of BLR with R&R undertaken by three different surgeons who
determined the type and amount of surgery to achieve orthotropia. It should be noted that one surgeon
had a strong preference for R&R, whereas the other two surgeons had a preference for BLR but would
undertake R&R if there was a tendency for deviation in one eye or a strong near component. Outcomes
were reported at 1 and 3 years postoperatively for both motor alignment (no reporting of number of
measurements taken) and control (subjective assessment by an orthoptist). The study reported clear
inclusion and exclusion criteria – patients were eligible if they had either basic or divergence excess type
X(T) and a deviation of between 25 and 50 PD. A successful outcome was defined as X(T) ≤ 10 PD.
At 12 months’ follow-up there was a statistically significant difference in the success rate of surgery
between the two groups, with better outcomes in the group receiving the R&R procedure (74.2%) than in
the group receiving BLR (42.2%; p< 0.001). However, the authors note that exotropic drift over time was
greater in the R&R group, with a significant increase in the mean distance constant exotropia (XT) in the
R&R group at 3 years’ postoperative follow-up (p= 0.01). There was no significant change in postoperative
deviation for either distance or near measurements in the BLR group. It is noteworthy that the authors
report significant differences between the two intervention groups, with the R&R group having a greater
mean age (p= 0.052), a higher proportion of children with divergence excess-type X(T) (p= 0.0181) and a
smaller mean angle of deviation (p= 0.0005) than the BLR group. These differences were not adjusted for
in the analyses, which limits the generalisability of the findings. The authors acknowledge that the wide
range in size of X(T) at baseline (up to 50 PD) might also affect interpretation of the study findings. Other
limitations include the absence of clear guidelines for choice of surgical procedure (no standard protocol of
tables for determining type or amount of surgery).
The comparison between R&R and BLR procedures was also examined in a retrospective study of
128 children.50 Surgical outcomes were assessed in a cohort of children with basic-type X(T) and at least
2 years’ follow-up (mean 44.2 months for BLR and 47.8 months for R&R). Success was defined as
esophoria/tropia ≤ 5 PD to exophoria/tropia ≤ 10 PD) measured on at least three occasions (this is the only
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study50 that explicitly reported measuring deviation on at least three occasions at baseline and follow-up).
The authors found no difference between the two interventions at 2 years postoperatively; however after
long-term follow-up (mean 3.8 years) the BLR procedure had a significantly higher success rate than R&R
(58.2% vs. 27.4%; p< 0.01). One of the strengths of the study50 is the long follow-up period used, which
identified greater recurrence in the R&R group (after mean 3.8 years’ follow-up, recurrence was 68.5% in
the R&R group vs. 38.2% in the BLR group). However; it should be noted that ascertainment bias is an issue
here, as patients with poorer outcomes might be more likely to be followed for longer. Equally, the inclusion
criteria for this study50 were less rigid, with the inclusion of patients with a A or V pattern, dissociated vertical
deviation or oblique muscle over-actions that did not require surgery. Further, there were statistically
significant differences between the two surgical groups in terms of preoperative deviation and this potential
confounding effect was not adjusted for in the analyses. The BLR group had a larger mean angle of
deviation at baseline but, even so, had better success rates at longer-term follow-up. The findings are also
limited by absence of data on sensory status, specifically stereopsis pre- or postoperatively.
The same surgical comparison was undertaken in a retrospective, single-centre study51 with a 1-year
follow-up period. The population of 3- to 17-year-old children (n= 103) was mixed in terms of type of
X(T), with 93 basic-type X(T) and 10 pseudodivergence excess-type X(T), and the aim of surgery was
deliberate overcorrection. The authors reported no significant differences between the two intervention
groups (BLR n= 46 and R&R n= 57) in terms of age or deviation at baseline. Success was defined as no
more than 10 PD of exophoria or 5 PD of esophoria (sparse detail was included on how outcomes were
measured). The authors reported no statistically significant differences in terms of success rate at 1-year
follow-up between the two groups [BLR 56.5% (26/46) vs. R&R 59.6% (34/57); p> 0.05], and age and
initial deviation had no significant effect on outcome (p> 0.05). The main objective of this particular
study51 was to understand the relationship between motor alignment at day 1 and motor alignment at
1-year follow-up. The authors conclude that optimal results are produced with immediate postoperative
overcorrection of 11–20 PD for BLR and 1–10 PD for R&R procedures. In terms of limitations of this study,
there is a lack of detail on how choice of surgical procedure was determined, although it is stated that
both procedures were performed by the same surgeon.
A large retrospective cohort study53 of children aged 15 years or younger (n= 666) explored long-term
outcomes of BLR (n= 349) compared with R&R procedures (n= 298). The study53 reports a paucity of detail
with respect to the baseline population, in particular type and severity of X(T); likewise, there is a dearth of
information available on the specific protocol for outcome assessment. A further limitation is that the
authors fail to explore (and take account of) baseline differences between the surgical groups in terms of
age and size of initial deviation. The authors do include, however, guidelines for surgery. Comparative data
are reported at 4 years’ follow-up for patients who initially showed orthotropia or minimicrotropia (defined
as alignment within 4 PD of orthotropia) at 1 month postoperatively. Of the patients receiving BLR, 66.7%
(140/210) retained orthotropia or minimicrotropia, whereas 32.8% who received R&R retained orthotropia
or minimicrotropia (with more patients drifting towards exotropia in this group). A subset of 78 patients
were followed for between 8 and 22 years but no comparative data for the two surgical techniques were
reported. Restoration of normal appearance was also conceptualised as a key indicator of success,
although there was no statistically significant difference between procedures in terms of success rates, with
95.2% of patients who received BLR achieving normal appearance compared with 80% of patients who
received R&R achieving normal appearance. Caution should be applied when interpreting success
outcomes, given that the definition of success is extremely broad (≤ 20 PD of heterotropia).
A retrospective cohort of children (aged 2–18 years) with basic-type X(T) also compared the R&R and BLR
procedures.55 Twenty-five children received R&R surgery on the non-fixating eye, whereas 30 children
received BLR surgery; the groups were comparable (i.e. there were no statistically significant differences
between the two groups) in terms of age, preoperative deviation and sensory results at baseline. The mean
follow-up period was 2.81 years, with a range of 6 months to 8 years; there is limited information about
how outcomes were assessed (e.g. use of repeat measurements). There were no statistically significant
differences between the two groups in terms of success rates at long-term follow-up (p= 0.249), with
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52% of patients achieving an optimal or good outcome (defined as orthotropia or within ± 20 PD of
orthotropia, respectively) in the BLR group compared with 57% achieving an optimal or good outcome in
the R&R group. In terms of limitations the sample size is small and the findings should be interpreted
in light of the retrospective study design.
In summary, the findings of the above studies (one RCT47 and five retrospective cohort studies49–51,53,55 with
comparison groups) show that short-term outcomes tend to be better with the R&R procedure, but there is
a suggestion of better long-term outcomes with BLR surgery.47,49–51,53,55
Conventional recession/resection compared with augmented
recession/resection
One study52 investigated the effectiveness of augmented surgery compared with conventional surgery,
using the symmetric lateral rectus recession procedure that was assessed in a population of 107 children
with basic-type X(T) followed for at least 6 months. Conventional surgery was conducted according to
Parks formula, whereas augmented surgery was 1.5–2.5mm more than a conventional lateral rectus
recession. Success was defined as between 8 PD of exophoria and 8 PD or esophoria, and follow-up was
6–35 months in the augmented surgery group compared with 6–39 months in the conventional surgery
group (sparse detail was included relating to outcome assessment). Conventional surgery was performed in
41 children (mean age 8± 3.6 years) and augmented surgery was performed in 66 children (mean age
7.1± 3.9 years). Comparison of success rates at the last follow-up visit demonstrated a statistically
significant difference favouring augmented surgery (68.2% vs. 43.9%; p= 0.01). One of the key
limitations of the study is that, although performed by the same surgeon, the two procedures were
conducted at different time points, so, in effect, the control (conventional surgery) was recruited historically
(both groups were recruited retrospectively but the control group was recruited earlier than the
intervention group). That said, the groups were shown to be comparable, with no statistically significant
differences between the groups in terms of mean alignment at baseline (p= 0.23), mean age (p= 0.06)
and mean length of follow-up period (p= 0.55). The authors also acknowledge that stricter success criteria
might be required, with the recognition that patients with 8 PD of esophoria can complain of diplopia.
Non-surgical interventions
Surgery compared with non-surgical interventions
Four studies20,42,48,54 compared surgical and non-surgical interventions, two of which reported comparative
findings on two interventions48,54 while the remaining two studies20,42 considered more than
two interventions.
Surgery compared with BOTOX
One prospective cohort study54 investigated the effectiveness of treatment with attenuated botulinum
strain A (BTXA) compared with surgery (including both unilateral and bilateral) in a population of children
aged 4–12 years. No information about the type of X(T) was reported. The method of recruitment was
non-randomised and outcomes were assessed at 2 weeks, 1 month, 3 months and 6 months post
intervention. Success was defined as a deviation within ± 10 PD of orthotropia, although limited details
relating to outcome assessment (e.g. number of measurements taken) was reported. Although the rate
of successful corrections was lower in the BTXA group (23/30, 76.67%) in comparison with the group
receiving surgery (27/30, 90.00%), the difference was not found to be statistically significant (p= 0.166).
In the BTXA group the undercorrection rate was (7/30, 23.33%). Conversely, in the surgical group one
case was undercorrected and two cases were overcorrected. The authors also reported complications for
the BTXA group, with one case of double vision (requiring patching); the authors mention that double
vision occurred for some of the other patients but not to the extent that it affected daily living; the authors
do not state the proportion of patients who experienced these symptoms of double vision. In addition,
seven cases of ptosis were reported, all of which resolved after 3 months.
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Surgery alone compared with surgery plus binocular vision training
A RCT48 of children, aged 5–16 years, explored the effectiveness of binocular vision training after surgery
for X(T). Patients were randomised to either the intervention group (n= 61), which involved a period of
binocular vision training, which began 2 weeks post surgery, or the control group (n= 60), which received
no training after surgery. Patients in the binocular vision training group completed exercises with red and
blue glasses three times per day for a period of 20 minutes on each occasion. There is a dearth of detail
regarding the intervention, in particular the period over which the exercises were undertaken and also the
type of X(T) under investigation. The primary outcomes were recovery of binocular vision and regression/
deterioration rate (defined as deviation of >± 10 PD); both were assessed at 1 week post surgery and
12 months post follow-up. The authors conclude that binocular vision was better in the training group
than the control at 12 months’ follow-up. Likewise the regression rate was worse in the control
group than in the intervention, with 21/60 recessing in the control group (35%) compared with 7/61
(11.5%) in the intervention group; this difference was statistically significant (p< 0.05). These findings
suggest that additional binocular vision training after surgery might improve outcomes.
Surgery compared with conservative interventions
Two studies20,42 considered surgery versus conservative interventions. Multiple intervention comparisons
were explored in a prospective, multicentre cohort study of 371 children aged < 12 years.20 Previously
untreated basic, true and simulated divergence-excess types were included and children were followed for
2 years for each of the non-surgical interventions (n= 50), for observation (n= 195) and for treatment
for reduced VA (n= 63), and 6 months postoperatively for the surgical intervention (n= 63).
The non-surgical treatment group (n= 50) included the following interventions that aimed to improve
control: spectacle lenses (n= 37); occlusion (n= 6); glasses and patching (n= 2); exercises (n= 4); and
exercises and prism (n= 1). Outcomes assessed included change in angle of deviation (no detail of whether
or not repeated measurements were used), control [Newcastle Control Score (NCS), which incorporates
both objective and subjective components: high score= poor control; scores range from 0 to 961,62] and
stereoacuity (Frisby Near Stereoacuity Test). The authors conclude that surgery was the only intervention
associated with statistically significant improvements in angle of deviation (p< 0.001) and NCS61,62
(mean 60% reduction in both parental and clinic components). However, there was a risk of overcorrection
(21% at 6 months) and additional surgery was required in 8% of children (5/63). Non-surgical interventions
had no significant effect on angle of deviation, but significant small improvements in control were noted
for the non-surgical intervention and observation groups (mean reductions of 20% and 13% in the clinic
and parent components, respectively). Another key finding was that few children in the watchful-waiting
group showed deterioration to constant exotropia (0.5%); however, follow-up was limited to 2 years.
One of the strengths of this study20 is that children were recruited from 26 centres and loss to follow-up
was not significant (with 81% of the original cohort being available for final follow-up). The authors also
established that there were no significant differences between the final samples and those lost to
follow-up. A possible weakness of this study is the absence of robust criteria/protocol for management
decisions. However, the study was multicentre and the authors argue that treatment adopted was likely to
reflect current practice at the centres involved. A second limitation surrounds comparison of the outcomes
of surgery at 6 months compared with non-surgical intervention outcomes at 24 months, which the
authors acknowledge may introduce bias in interpretation of the study findings.
A retrospective study of 150 children compared four different treatment options for X(T): (1) surgery only
(BLR using recognised guidelines, n= 15); (2) surgery combined with orthoptic/occlusion therapy (n= 67);
(3) orthoptic/occlusion therapy alone (48); and (4) observation (n= 20).42 Within the orthoptic/occlusion
group, treatment was divided into the following subgroups: convergence exercises, overminus lens
therapy or occlusion therapy. For orthoptic/occlusion therapy before surgery, an additional intervention
of preoperative diplopia awareness exercises was undertaken. Children, aged < 15 years, with an
exodeviation of 15 PD for distance fixation were included and followed for a maximum of 5 years.
Patients were not randomised to the intervention groups; the authors state that treatment method was
‘largely dependent on parent preference’, which might represent a source of bias. Success was defined as
orthophoria or < 10 PD esotropia/exotropia (no reporting of protocol for assessment of angle of deviation),
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good stereoacuity (Lang stereotests) and cosmesis (parental subjective assessment). Comparison of change
in deviation for each of the intervention groups revealed that surgery coupled with orthoptic/occlusion
therapy produced the greatest mean reduction in exodeviation, the difference was significantly greater
than with the other interventions at all follow-up time points (p< 0.001). There were no statistically
significant differences in success rates between the subgroups of preoperative orthoptic/occlusion
exercises. In terms of study limitations, the authors fail to explore the potential confounding effects of age
and severity of X(T) at baseline. From baseline data it appears that the groups were not comparable in
terms of mean age, sensory results and mean preoperative deviation, although no statistical assessment of
difference across the intervention groups in terms of baseline characteristics is reported.
Adverse effects
Of the 11 included studies,20,42,47–55 1020,42,47,49–55 reported outcomes relating to adverse effects. Nine studies
evaluating surgical interventions20,42,47,49–53,55 reported overcorrection rates, which ranged from 1.5%52 to
21%.20 In four49–51,55 of six studies47,49–51,53,55 comparing BLR and R&R procedures, overcorrection rates were
greater in the group undergoing the R&R procedure (overcorrection rates by individual study are shown
in Table 1). One of the prospective cohort studies, which examined the effectiveness of BOTOX in
comparison with surgery, found that some adverse effects were reported in the BOTOX group: diplopia
(which required patching, in one patient) and ptosis (eyelid droop, in 7 of 30 patients – 23%) but these
tended to resolve over time (6/7 cases improved after 1 month and all cases improved after 3 months.
None of the remaining non-surgical interventions (overminus lenses; occlusion; orthoptic exercises; prisms)
was associated with adverse outcomes.20,42,48
TABLE 3 Quality appraisal of non-randomised studies (CASP 2011,46 CRD 2001,39 Deeks 200360)
Quality criterion
Buck
201220
Chia
200649
Choi
201250
Figueira
200642
Lee
200151
Lee
200752
Maruo
200153
Wu
200854
Yuksel
199855
Was the cohort recruited in
an acceptable way (robust
inclusion/exclusion criteria
or consecutive recruitment)?
Y Y Y Y Y Y U N N
Was the study prospective? Y N N N N N N Y N
Was the intervention
conducted in an explicit
and standardised manner
(i.e. were guidelines or
protocol for intervention
described)?
N N Y N Y Y Y U Y
Was the outcome
appropriately measured to
minimise bias?
Y Y Y Y Y Y N Y N
Did they identify important
confounding factors
(e.g. age at intervention,
baseline angle of deviation)?
Y Y Y Y Y Y N Y Y
Did they adjust for
confounding factors in the
design and/or analysis
where necessary?
N N N N Y Y N Y Y
Were they followed up for
at least 12 months?
N Y Y Y Y Y Y N Y
Are the authors’ conclusions
substantiated by the
reported data?
Y Y N Y Y Y N Y Y
N, not addressed; U, unclear or not reported; Y, adequately addressed.
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Discussion
Summary of main results
Surgical intervention studies
The review revealed mixed findings when comparing R&R and BLR surgery, with two studies51,55 reporting
equivocal results, two studies47,49 favouring R&R surgery, and two studies50,53 reporting more success with
BLR surgery at long-term follow-up. R&R surgery produced more successful results, at least in the short term,
with two studies47,49 reporting statistically significant results favouring R&R procedures. However, there are
reservations around the stability of outcomes for R&R surgery in the long term, with studies49,50 suggesting
greater exotropic drift over time. The BLR procedure produced better outcomes at long-term follow-up
(at least 3 years) in two studies.50,53 The reader should be aware that the study populations are different – we
are not comparing like with like – some studies examine only basic-type X(T), whereas others include both
basic and divergence excess types. Equally the follow-up point for measuring a successful outcome was
defined differently, so these comparisons should be interpreted with caution. In terms of adverse effects, the
rate of overcorrection was variously reported (range 1.552–21.00%20). The wide range in overcorrection rate
is probably due to differences in the follow-up period between studies and the definition of overcorrection
applied (e.g. strict definitions, i.e. any esotropia20 vs. looser definitions, e.g. esotropia > 8 PD52).
Non-surgical studies compared with surgical intervention studies
Only four studies20,42,48,54 meeting the design criteria (RCT, quasirandomised study or cohort study with
comparison group) were located, each considered different interventions and comparison groups so it is
difficult to synthesise results even tentatively. The prospective study comparing surgery, non-surgical
interventions and observation found that surgery produced better outcomes in terms of motor alignment
and control, but it was associated with a significant risk of overcorrection, with loss of near stereoacuity
in some cases.20 Importantly, the authors also conclude that watchful waiting is not associated with
deterioration and progression to constant exotropia within the first 2 years after diagnosis. The RCT of
vision training after surgery demonstrated more successful outcomes when compared with surgery alone.48
The prospective study54 comparing treatment with BTXA with surgery found no statistically significant
difference in success rates between the two procedures, but argued that BTXA represented a less invasive
option when adverse effects (ptosis and diplopia) are only short lived. A retrospective study of multiple
interventions reported orthoptic exercises or occlusion prior to surgery resulted in greater success when
compared with surgery alone; there were no significant differences between the success rates of either
orthoptic exercises or occlusion.42
Quality of evidence
The body of evidence retrieved was limited in terms of size and quality. Only two RCTs47,48 were located, both
of which had a risk of bias attributed to aspects of the study design (no masking of outcomes assessment and
the possibility of selection bias). Both prospective cohort studies20,54 had comparison groups but neither was
matched. The main sources of bias in the retrospective studies with comparison groups were small sample
sizes, short follow-up periods, absence of a robust protocol for management or allocation to intervention
groups, and limited adjustment for known confounders, such as age and initial deviation at baseline. But
perhaps more important is the variability in outcome measures used and, specifically, the definition of success
applied (e.g. broad vs. narrow thresholds to constitute success). These limitations were coupled with a paucity
of detail on study methods, making it difficult to establish how interventions were undertaken (e.g. absence of
guidelines or standardised protocol for surgery), how outcomes were assessed (e.g. lack of detail on specific
tests used) and whether or not there were any differences between intervention groups at baseline (especially
with regard to age and initial deviation).
Comparison with the existing evidence base
Commensurate with the conclusions of the earlier Cochrane review27 we found that there remains a need
for further well-designed RCTs to examine questions of effectiveness for different management options of
childhood X(T). Given the absence of high-quality evidence, the authors argue for prudence when
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considering management options given the potential to ‘do harm by correcting the appearance
of misalignment but disrupting the ability to maintain binocular stereo vision’,27 p.10. A review of
conservative treatment options for X(T)24 found that interventions such as minus lenses, anti-suppression
occlusion and orthoptic exercises were effective both as an alternative, and as an adjunct, to surgery but
they also highlighted a need for further research to understand the circumstances under which these
management strategies were most successful, in particular dosage of antisuppression occlusion therapy.
Similarly, a review of non-surgical interventions for X(T)45 underlined the dearth of well-designed
intervention studies to examine questions of effectiveness. They highlighted the absence of consensus
definitions of success as well as poor reporting of details around the actual intervention delivered and
compliance with this. Our review supports each of these calls for further better-designed studies,
consensus on outcome measures of success and improved reporting of interventions and outcomes.
Potential biases in the review process
The main limitation of this review is that we are reporting on effectiveness with suboptimal study design.
The RCT is the design of choice when addressing questions of effectiveness. Owing to the absence of RCTs
in this topic area, we have adopted a pragmatic approach, moving down the hierarchy of evidence to the
next level when studies were available (i.e. cohort studies with a comparison group, both prospective and
retrospective). By including non-randomised (observational) studies we are aware of the issue of selection
bias due to the absence of robust methods of allocation (usually by clinician, which increases the risk of
confounding by prognostic factors such as age or severity of the condition at baseline).40 Far more case
series were retrieved in the searches but, owing to the absence of a contemporaneous comparison group,
we have excluded this study design.63 The dearth of high-quality study designs, together with the
considerable heterogeneity between studies in terms of population [i.e. type of X(T)], outcomes measured,
definition of success and follow-up period used, precluded a meta-analysis that would be the ideal form
of synthesis for a review of this nature.
We should also acknowledge that, although searches were conducted across multiple databases and
supplemented by hand searches of non-indexed journals and contact with key experts in the field, it is
possible that we may not have captured all relevant studies. That said, the search strategy was developed,
piloted and refined by a highly experienced information researcher and efforts were made to contact key
experts in the field using an established discussion list. In using these research findings, researchers and
practitioners alike should be mindful that studies were retrieved using the search strategy presented in
Appendix 1 and by applying the strict eligibility criteria set out in Box 2. We excluded studies if they did
not report outcomes for children (up to 18 years) with X(T) (either basic or divergence excess types)
separately. In other words, studies were excluded if they reported aggregated outcomes for exotropia
generically (e.g. constant and intermittent mixed or for children and adults mixed). If time and resource
constraints had allowed, we would ideally have contacted study authors of studies with mixed populations
(adults and children; XT and X(T); convergence insufficiency type combined with divergence excess) to
request disaggregated data.
One of the strengths of our review was the inclusion of foreign-language papers (n= 3), which is
particularly important for the topic area given the epidemiology of X(T).27 It should be noted, however, that
the website and hand searches were conducted in English language only. Publication bias might also be an
issue here, with studies presenting equivocal or non-significant results not being published.
The review has sought to address questions around effectiveness of interventions for X(T) in children.
We included the best available level of evidence (mostly cohort studies with a comparison group) to
examine intervention effectiveness. The study design used might not be the most appropriate to address
our secondary objectives around the natural history of X(T) and adverse effects. Thus we recommend
additional reviews to consider these questions. For example, a review of inception cohort studies would
be most appropriate study design to consider evidence of adverse effects associated with different
interventions for childhood X(T). Likewise, patient registry studies are suitable to explore the natural history
of X(T) in children, observe disease progression and understand long-term outcomes.
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Conclusions
Although being mindful of the limitations of observational data to compare the effectiveness of different
treatment options, the findings suggest that in some circumstances R&R surgery can produce better
outcomes than BLR surgery; however, there is a question about the sustainability of success with the
possibility of regression over time. The extent and quality of the evidence have clear limitations that future
studies, ideally RCTs or well-designed prospective controlled intervention studies, should address. We look
forward to the results of the North American RCTs on efficacy of type of surgery, BLR compared with
R&R,29 and observation therapy compared with occlusion therapy for treatment of X(T).30 The implications
of this review for research and practice are summarised in Box 3. To echo the conclusions of Hatt and
Gnanaraj,27 consensus is needed as to what constitutes the ideal measure of success, as well as agreement
on how this should be measured. Related to this point is the time at which outcomes should be measured
post intervention (e.g. 6 months, 1 year, 2 years) as we recognise that surgical outcomes in particular are,
to some extent, plastic, with possible drift over time.
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BOX 3 Implications for practice and research
Implications for practice
On the basis of the findings presented here we tentatively suggest that R&R surgery produces better outcomes
in the short term but there is a tendency for deterioration over time.
Surgical outcomes might be improved by coincident additional therapy, such as orthoptic exercises/occlusion
prior to surgery or binocular vision training therapy after surgery.
Although non-surgical interventions seem to be less effective in terms of improving angle of deviation, they are
rarely associated with adverse outcomes.
We await the results of the ongoing RCTs comparing (1) the effectiveness of BLR and R&R surgery and
(2) the effectiveness of occlusion to watchful waiting.
Recommendations for research
There is a need for well-designed and conducted RCTs to address the question of intervention effectiveness for
treatment of divergence excess or basic X(T) in children.
There is a need for a consensus on outcome, how this should be measured and at what time point(s). One
approach to address this issue might be to conduct a Delphi survey with experts in the field.
We would encourage authors of future studies to include more detail on how interventions were designed and
delivered (e.g. more details on allocation to interventions and measurement of outcomes). Likewise we call for
better reporting of methods in future studies.
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Chapter 3 Methods
Trial design
The SamExo trial was a rehearsal pilot RCT to assess the feasibility of a full RCT of the effectiveness of
surgical treatment against active monitoring in X(T). The trial was conducted according to
recommendations for good practice in pilot studies.64 Fuller detail about the protocol can be found
in our publication.65
Changes to trial design
Ethical approval
The study was reviewed by the Sunderland Research Ethics Committee (REC) on 18 October 2010 and
Mr Michael Clarke, Chief Investigator, and Ms Christine Powell, Co-Investigator, were in attendance.
A favourable opinion was given dependent on minor amendments to the Parent Information Sheet and
the introduction of a supplementary Parent Information Sheet for parents who declined to take part, which
were subsequently agreed. The quality of the documents submitted was commended by the committee.
Amendments to ethical approval
Throughout the course of the study, three substantial amendments were submitted to Sunderland REC for
review. All three were granted ethical approval.
Amendment 1 (submitted on 7 July 2011)
The main changes to the protocol were first to the inclusion and exclusion criteria; amendments were
made in order to make the criteria clearer to the treatment orthoptists (TOs) and to allow the inclusion of
families who did not have English as a first language.
Two new health-economic questionnaires were submitted for REC review. These were used to assess
participant’s costs for time and travel, and the use of the health service.
It was found that the original QoL questionnaires were not suitable for children of < 5 years of age,
therefore a new QoL questionnaire [Pediatric Eye Disease Investigator Group Intermittent Exotropia
Questionnaire (IXTQ)]66 was submitted for review. The IXTQ is a validated three-part, patient-derived
health-related quality of life (HRQoL) measure. It has three questionnaires:
1. Parental Asks parents to rate their own HRQoL.
2. Proxy Assesses parental perceptions of the child’s HRQoL.
3. Child For children ≥ 5 years of age, to rate their own HRQoL.
Amendment 2 (submitted on 23 September 2011)
The main change was to the inclusion criteria for ocular alignment evidence. This was to allow the use an
alternative test for near stereo acuity (the TNO test for stereoscopic vision) for patients who were unable to
cooperate with the Randot test.
The procedure for contacting parents who had expressed interest in the study was also revised.
A designated deputy was added to the delegation log in order to assist the TO in contacting the parents
by telephone. This was to cover the TO during annual leave.
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Amendment 3 (submitted 28 November 2011)
An amendment was submitted in order to ask parents who had declined to allow their child to take part
in the study to attend a routine follow-up appointment at 9 months with their child. At this appointment
consent would be taken from these parents to allow us to use pseudonymous clinical data collected on
their child at the visit, at which they consented, and compare it to the data collected at the 9-month
follow-up visit. The aim of this amendment was to help us check that the children who had taken part
in the study were representative of all children with X(T) and to find out the proportion in the non-study
group who went on to have treatment for control.
A new consent form was developed for this group of people and a new Participant Information Sheet
about why we wanted to carry out this substudy was produced.
Research and development approval
As a National Institute for Health Research (NIHR) Portfolio study, the NIHR Coordinated System for gaining
NHS permission was applied for via Northumberland Tyne and Wear Comprehensive Local Research
Network. No difficulties were encountered with this process.
Participants
Children aged between 6 months and 16 years, who were referred to the clinics with suspected X(T) from
community screening, general practice or other health-care professionals, and subsequently diagnosed
with X(T), as well as existing patients fulfilling the eligibility criteria, were eligible for the SamExo study.
The parent/guardian provided written informed consent for participation in the study prior to any
trial-specific procedures.
Data were anonymised by use of a unique trial identification number (ID) assigned by the online trial data
management database post consent.
Inclusion criteria
l Age between ≥ 6 months and ≤ 16 years.
l Evidence of X(T) on the basis of parental history and clinical examination.
l No ongoing or planned amblyopia treatment.
l VA of 0.500 or better on an age-appropriate logMAR (logarithm of minimum angle of resolution) test or,
where uniocular testing is not possible, central steady maintained fixation when one eye is occluded.
l NCS61 of ≥ 3.
l Minimum of 15 PD misalignment in the distance.
l Presence of near stereopsis documented using the preschool Randot test if ≥ 3 years of age.
l If < 3 years old must be able to overcome a base-out prism (10, 15 or 20 PD).
Exclusion criteria
l Age > 16 years.
l Previous treatment for X(T).
l XT (other than microtropia).
l VA of > 0.500 logMAR in either eye.
l X(T), where near misalignment is > 10 PDs more than the distance misalignment.
l Structural ocular pathology.
l Significant neurodevelopmental delay.
l Families planning to move out of area.
METHODS
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Study setting
Four secondary ophthalmology care facilities at The Newcastle upon Tyne Hospitals NHS Foundation Trust
(co-ordinating site), City Hospitals Sunderland NHS Foundation Trust, Moorfields Eye Hospital NHS
Foundation Trust and York Hospitals NHS Foundation Trust, each of which are large centres with specialist
paediatric ophthalmology clinics.
The sites (York, Sunderland and Moorfields) were chosen on the basis of their willingness to collaborate
with the study and previous experience of collaboration on similar studies.
The patient demographics were significantly different at Moorfields, with a higher variation in ethnicity
of the patient population than in the other three sites.
Initial site visits were carried out to each site in order to introduce the study protocol and test procedures.
Planned recruitment figures were discussed and any possible issues flagged up early on in the set-up phase
of the study.
Feedback from the initial meetings was positive; however, the York and Sunderland sites did express
reservations regarding their ability to recruit to target.
Interventions
Identification of potential participants and invitation to participate
(See Figure 2.)
The initial strategy for recruitment was to identify and recruit children newly diagnosed with X(T).
At each site, attempts were made to identify new referrals of children with X(T). In Newcastle, these
referrals were booked into specific research clinics. In the other three sites, potential participants in the trial
were booked into specific appointment slots within regular clinic sessions.
Apart from general practitioner (GP) referrals, some children were referred on the basis of school vision
screening tests, which were carried out in the Sunderland and Newcastle areas.
At the initial appointment, potential participants were screened by the TO and Principal Investigator (PI) at
each site for eligibility, and an eligibility screening log was completed to document participants’ fulfilment
of the entry criteria. The log also ensured that potential participants were approached only once.
During this visit to the hospital eye service, eligible children were clinically assessed in the normal way
and the clinical team introduced the study during the discussion of treatment options and the evidence
that was available for each treatment option. Eligible patients were also provided with full study
information at this point. Patients who were found not to be eligible resumed normal care.
After at least 24 hours, parents were contacted by the TO or another designated member of the study
team by telephone to confirm that they had read and understood the study information, and any
questions regarding the study were answered.
All children were then booked into the next available recruitment clinic, which was within 8 weeks of the
screening visit.
If consent to further contact about the study was declined then the child entered back into normal care.
Reasons for declining to participate in the study were logged by the local PI or delegated deputy.
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Consent to later contact for interview about reasons for and against participation in the study was also
logged, by the local PI or delegated deputy, for those patients who would not be subsequently attending a
recruitment clinic. At all stages of this process, it was made clear that consent to participate in the study
was entirely voluntary and declining to participate would have no impact on subsequent routine care.
Parents of children who did attend the recruitment clinic, were also asked if they were willing to complete
a telephone interview with a qualitative researcher concerning their reasons why they either did or did not
want to participate in the study.
Consent was also sought from parents who declined to allow their child to take part in the study but who
were willing to attend a routine follow-up appointment at 9 months with their child. At this appointment,
pseudonymous clinical data were collected and used in conjunction with previous clinical data collected,
in order to assess the extent of participation bias at both recruitment and follow-up.
Clinic appointments
Figure 2 illustrates the schedule of study visits and corresponding assessments for the active monitoring
and surgery arm. The assessments involved routine clinical measurements together with the evaluation of
QoL using the IXTQ66 (see Appendix 5), a Health Services Use Questionnaire (HSUQ) and a Time and Travel
Costs Questionnaire (TTQ) (see Appendix 7). Children in the active monitoring group were offered surgery
if a constant strabismus (XT) appeared to be developing or parents requested surgery and the responsible
clinical team agreed that this was appropriate. Constant exotropia was defined as NCS 9 with no
demonstrable binocular single vision.
Eye muscle surgery
Surgery was performed by the local PI or delegated deputy, in accordance with agreed surgical formulae
tailored to the clinical characteristics of the strabismus and the usual practice of the surgeon. Principles
involved in the surgical treatment of children in the study were agreed as follows:
l general anaesthesia
l BLR surgery to be performed for true-distance exotropia
l unilateral recession/resection surgery to be performed for other types of exotropia
l standard sterile preparation of the operative site
l conjunctival incisions
l standard isolation and cleaning of muscle to be operated
l muscle secured with 6/0 VICRYL® (polyglactin 910) suture (Johnson & Johnson, New Brunswick,
NJ, USA)
l amount of R&R assessed on the basis of the maximum distance angle according to table, modified
according to standard practice of surgeon
l measurement of amount of muscle adjustment to be checked post placement of scleral sutures
l conjunctival incisions closed with VICRYL sutures
l topical anaesthetic and antibiotic drops given at end of procedure.
A surgical table was used with modification as appropriate to determine the amount of eye muscle
movement to be performed depending upon the size of the angle of exotropia. Surgical technique was
carefully recorded and monitored during the pilot, with a view to standardising surgical technique –
as far as it was possible to do so – in a full trial and provide a clear description of the intervention in
subsequent reports.
Primary outcome visit
The final assessment (9-month outcome) was conducted by a research orthoptist (RO) who was masked to
the allocation of the child and was not otherwise in contact with children enrolled in the study. The parent
and child were requested not to reveal the group allocation of the child to the RO prior to the assessment.
Although children have noticeably red eyes immediately following eye muscle surgery, it is recognised that
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this redness resolves within 6 weeks when this is a first procedure. Residual scarring of the conjunctiva
following eye muscle surgery will be inconspicuous by 6 months.
Parent interviews
We gathered qualitative data (primarily through telephone interviews) from parents to explore their
reasons for either accepting or declining participation in the pilot study, their thoughts on randomisation
and the study information received, and any ideas they may have had for improving the trial. These data
would inform the design of a full RCT. Although the principles of informed consent meant that individuals
were not obliged to give a reason for their decision if they did not want to, we invited parents to take part
in a telephone interview if they agreed to this level of involvement. Without this information, it is difficult
to see how research design can be improved to make it more acceptable. These interviews were
Children aged 6 months to 16 years who are:
a) referred from community screening, GPs or other health professionals
b) existing patients with untreated X(T)  
Initial clinic visit for new referrals: routine clinical assessment;
discussion about management of X(T) and study information
Telephone call from member of study team to resolve any queries
Recruitment clinic:
Initial clinical data checked to confirm eligibility; informed consent sought;
centralised web-based randomisation and QoL evaluation
Active monitoring  
3 months after recruitment
3-month monitoring visit
(clinical, HSUQ and TTQ
assessments by TO) 
6 months after recruitment
6-month monitoring visit
(clinical and HSUQ
assessments by TO)
9 months after recruitment
Blinded 9-month outcome visit
(clinical, QoL and HSUQ
assessments by RO)
Surgery  
3 months after recruitment
Pre-assessment and surgery
within 3 months; 2-week 
post-operation visit (clinical and
HSUQ assessments by TO)
~6 months after recruitment
3-month post-operation visit
(clinical, HSUQ and TTQ
assessments by TO)
~9 months after recruitment
Blinded 6-month post-operation
outcome visit (clinical, QoL
and HSUQ assessments by RO)
FIGURE 2 Summary of study visits, assessments and interventions. HSUQ, Health Services Use Questionnaire;
RO, research orthoptist; TTQ, Time and Travel Costs Questionnaire.
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conducted by a university researcher who was entirely separate from the clinical team, emphasising that
parents’ decisions not to participate have been respected and reassuring that no attempt was being made
to change their minds. A total of 48 parents who consented to the telephone call were interviewed, 34 of
whom had declined and 14 of whom had agreed participation in the trial. Most (40) were mothers and
eight were fathers. Interviews took on average 10 minutes (minimum 5 minutes, maximum 30 minutes).
These parents had been approached about the trial between September 2011 and May 2012.
Planned outcome measures
There are three classes of clinical measure that could be used as outcome measures for the treatment
of X(T).
1. Stereoacuity This is normally preserved for near fixation in affected children and will generally be
unchanged by treatment unless it deteriorates as a result of surgical overcorrection of the development
of a constant squint. Stereoacuity at distance may be affected but is not easily measurable and has high
test/test variability.
2. Ocular alignment This is measured in PDs for near and distance fixation. It may be measured by a
simultaneous prism cover test, which attempts to capture the alignment before binocular vision is
disrupted, or on an alternating prism cover test, which is the total misalignment demonstrated by
disrupting binocular vision by covering each eye in turn. In practice, binocular vision is easily disrupted in
children with the condition and the usual reported measure is the total misalignment on an alternating
prism cover test. The limitation of this measure is that alignment may be improved at the expense of
deterioration in stereoacuity, if a constant, but small, misalignment is a consequence of treatment.
Hence, as an outcome measure, this may overestimate the benefit of treatment by concentrating on
the cosmetic outcome at the expense of the functional outcome. Neither does it attempt to measure
the frequency with which misalignment occurs, which is a key factor in assessing the success of
intervention in a condition in which ocular misalignment is intermittent.
3. Control This is measured using either the NCS61 or the Mayo scale19 for the condition. Both are suited
to the assessment of an intermittent misalignment as is seen in the condition, and measure the
frequency with which the misalignment occurs and the ease with which realignment occurs. Possible
scores range from 0 to 9 and from 0 to 10, respectively; higher scores denote poorer control.
We feel that, because of the limitations of measures of alignment, a combination of measures of control
and stereoacuity represent the most appropriate clinical outcome measures for treatment of the condition.
For children with X(T), and their parents, the most relevant outcome from intervention is the restoration
of normal eye alignment, with associated cosmetic and functional benefits. The primary outcome in a
full-scale trial would be the difference in the cure rate of X(T) between the surgical and actively monitored
group; this was also the primary outcome for which data were collected in the current pilot in order to
inform sample size calculations for a definitive RCT. Cure was defined as:
l a control score (NCS61) of 0 (misalignment never noticed by parents, no observable deviation on
cover test)
l demonstrable near stereoacuity in children over 3 years of age.
Secondary outcomes included age-specific QoL assessments, satisfactory control of exotropia assessed
by parental report and clinical components of the NCS61 and the Mayo score,19 rates of amblyopia,
use of health-care resources, NHS costs, costs to families accessing the treatments being evaluated
and incremental cost per cured patient (with cure as defined by the primary outcome) and a
cost–consequences analysis based on incremental cost with respect to changes in all relevant outcomes
where possible.
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With respect to the choice of QoL measure, we know from our previous work with the Pediatric Quality of
Life Inventory20 that there is little or no effect of the condition on the scores obtained, so we sought an
alternative generic instrument that would capture any visual or psychosocial effect of the condition. We
proposed the use of the Health Utilities Index Mark 3 (HUI3) in this study but found it unsuitable for the
age of the population involved. In a longer-duration study, where the views of older children and their
parents could be captured at outcome, the HUI3 may prove to be an acceptable generic instrument. We
therefore used the newly developed condition-specific IXTQ.66
The key outcomes of this pilot study were:
l data on the variability of the primary and secondary outcome measures
l rates of participant recruitment and randomisation
l nature and extent of participation bias
l rates of crossover and retention of recruited participants
l nature and extent of biases arising from crossover or loss to follow-up.
An initial recruitment rate of > 60% and a retention rate of > 70% was considered necessary to indicate
feasibility of a full-scale RCT.
Our intention in the full trial would be to conduct a cost-effectiveness analysis based on incremental cost
per cured patient (as defined by the primary outcome) and a cost–consequences analysis based on
incremental cost with respect to changes in all relevant outcomes where possible, including the QoL
measure and different clinical measures. In this study we assessed the ease of collecting information on
outcome and costs needed for the health economics analysis.
With respect to collecting costs data, we piloted the TTQ and HSUQ that captured patient costs and the
NHS costs. We assessed the response and completion rates of these instruments. Patient costs included
travel costs for accessing NHS primary and secondary care; time costs of travelling and attending NHS
primary and secondary care; and self-purchased health-care and related management costs. NHS costs
comprised use of health-care resources in both primary and secondary care. Total costs consisted of patient
costs and the NHS costs compared with the randomised interventions.
Sample size
A formal power calculation was not performed for this feasibility study. It was not powered to detect a
clinically or economically meaningful difference in the primary outcome between the surgical and active
monitoring groups. Rather, the aim was to provide robust estimates of the likely rates of recruitment and
retention, and to yield estimates of the variability of the primary and secondary outcomes to inform power
calculations for a subsequent full-scale RCT. We originally estimated that over a recruitment period of
6 months (subsequently extended to 9 months) across four centres we would be able to approach
240 patients who met the entry criteria. From their responses we would be able to determine whether or
not the study is acceptable to parents and consequently whether or not it is possible to recruit patients and
follow them up. We would also be able to estimate attrition rates. By approaching 240 children/parents
we would be able to estimate the recruitment rate with a standard error no larger than 3.3%. Assuming
that half of these children were actually recruited we would be able to estimate the 6-monthly attrition
rate with a standard error of ≤ 4.3%.
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Randomisation
Randomisation was in permuted blocks, stratified by collaborating centre, age and severity of X(T), as
measured by the NCS.61 A blocked allocation (permuted random blocks of variable length) system was
used to allocate patients to the two groups in a 1 : 1 ratio to intervention (surgery) and control (active
monitoring) groups. Randomisation was administered using a centralised, password-protected, web-based
system that was managed by the Newcastle Clinical Trials Unit (NCTU).
As participants in the study were children of ≤ 16 years, consent was taken from the parent or legal
guardian; however, every effort was made to include the child in the consent process.
Once consent was obtained, the PI at site, or individual with delegated authority, entered the patient ID,
initials and the stratifying variables that then returned the allocation status. Participants were informed of
their group allocation and given the appropriate Group Allocation Information Sheet.
Children in the surgery group proceeded to surgical preassessment before undergoing standard eye muscle
surgery for X(T). They were then reviewed within 2 weeks of surgery and reviewed as was clinically
appropriate, depending on the result of the surgery, before further review at 6 months post recruitment
and final review at 9 months post recruitment.
Children in the active monitoring group proceeded to a clinic appointment arranged for 3 months’ time.
Further review took place at 6 months post recruitment and then final review at 9 months post
recruitment, as for the surgery group. At the final review at 9 months post recruitment (6 months
post surgery), clinical outcome measures were obtained for subsequent analysis.
Masking
As surgery was the intervention of interest, it was not possible to mask participants or parents to their
group allocation. Masking of investigators was achieved by the designation of a TO and a RO at each site.
TOs could not be masked to the group allocation of participants, as they conducted all assessments other
than the outcome assessment, and dealt with queries from parents/children during the course of the trial.
Clinical examination at the primary outcome visit was carried out by the ROs who were unaware of
treatment group allocation. At this final study visit, the success of masking was assessed by asking the
outcome assessor: ‘Do you think the patient has had surgery or not? Why do you think this?’ Their
responses were recorded on a separate form.
Statistical methods
For primary outcomes Student’s t-tests and Mann–Whitney U-tests were used to compare age and severity
of X(T) of those participants retained with patients withdrawing from the trial, and to compare those who
consented with those eligible but refused to participate. A Fisher’s exact test was carried out to assess
variability of the primary outcome (difference in cure rate at the final assessment between the surgery and
active monitoring arm); effect size [95% confidence intervals (CIs)] is also reported.
For secondary outcomes A chi-squared test was used to compare rates of satisfactory NCS61 outcome
between groups; odds ratios and 95% CIs are also reported. Rates of development of amblyopia in the
two groups were determined by monitoring VA at the 3-, 6- and 9-month assessments. For the QoL
measurements, we were primarily concerned with response and completion rates for those instruments in
both groups; in addition, their validity was assessed by matching individual pre- and post-treatment scores
to the post-treatment primary outcome, using Student’s t-tests.
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Statistical significance was set at p< 0.05. Data were analysed with the SPSS statistical package [SPSS
(Statistical Package for the Social Sciences) Inc., Chicago, IL, USA], version 19.
Adverse event reporting
Adverse event reporting was undertaken in accordance with the National Research Ethics Service
guidelines for adverse event reporting in trials that do not involve investigational medical products.
Definition of serious adverse event
A serious adverse event (SAE) (Table 4) was defined as an untoward occurrence that:
(a) resulted in death,
(b) is life-threatening
(c) required hospitalisation or prolongation of existing hospitalisation
(d) resulted in persistent or significant disability or incapacity,
(e) was otherwise considered medically significant by the investigator.
Trial management processes
The Trial Management Meeting Schedule for the SamExo Trial included:
l Trial Management Group Meetings Monthly study management meetings were held between
members of the NCTU (Senior Trial Manager and Trial Manager), the Chief Investigator and the core
study staff at Newcastle. This meeting reviewed the progress at all sites.
l Newcastle Study Group Meeting A further monthly study meeting was held between the Trial
Manager, the Chief Investigator and the research staff at Newcastle. This meeting reviewed the
progress at Newcastle. Both meetings were minuted.
l Monthly minuted conference calls were held between all PIs (Robert Taylor, York; John Sloper,
Moorfields; Peter Tiffin; Sunderland) and the Chief Investigator. TOs could also dial in if they had any
issues to discuss.
l Four Trial Steering Committee (TSC) Meetings were held, chaired by Professor Charlotte Wright.
TABLE 4 Expected adverse events
Procedure
Adverse event
Common and well understood
consequences of treatment Rare events
Perforation of the globe Occurring within 24 hours Occurring after 24 hours
Intraocular infection Occurring within 2 weeks Occurring after 2 weeks
Lost or slipped muscle Occurring within 1 month Occurring after 1 month
Scleritis Occurring within 1 month Occurring after 1 month
Becoming constant XT Occurring within 9 months Occurring after 9 months
Persistent overcorrection Occurring within 9 months Occurring after 9 months
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Good clinical practice training
All staff involved in the study were required to complete Good Clinical Practice (GCP) training. As this
study was portfolio adopted, GCP training was provided free of charge through the NIHR.
Site initiation visits
Each site received the Investigator Site File (ISF) with a CD-ROM containing all of the documentation for
the Pilot Rehearsal Trial and had a site initiation visit from the Trial Manager and the Co-Investigator,
Christine Powell, in advance of patient recruitment. This visit covered training in use of the various logs
within the ISF (screening, delegation, etc.), briefing on which paperwork was relevant at each stage and
safety reporting using the Serious Adverse Event form and issues such as version control of documents. A
‘typical’ patient route through the study was included, allowing site staff to talk through the practicalities
of recruitment. Training was also provided on the electronic Case Report Forms and the web-based
randomisation system.
Throughout the Pilot Rehearsal Trial, PIs and TOs were encouraged to contact the Trial team with any
queries they had.
Several communication strategies were adopted to encourage retention and fidelity to protocol. These
were mainly personal contact through telephone, e-mail and face-to-face meetings. Other methods of
communication included the SamExo website (http://research.ncl.ac.uk/samexo/). The website served a dual
role of being a point of reference for the study staff and a means of sharing information with the general
public. Feedback from the orthoptists, children and parents involved in the trial was very positive.
Facebook was also used as a more novel method of communication and a way to share non-sensitive
information with the general public (www.facebook.com/pages/The-SamExo-research-study/
279725438765959).
The experiences of the participating sites were captured during a final face-to-face SamExo team meeting
after the end of follow-up.
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Chapter 4 Results
Site recruitment and retention
All sites that began recruitment of patients were retained throughout the Pilot Rehearsal Trial and all have
expressed an interest in continuing with a full trial. A web-based survey of other ophthalmology units in
the UK was conducted (via e-mail discussion group PAED-OPHTH-STRABISMUS list: 157 recipients) and
responses were obtained from 37 units treating X(T) (see Appendix 6). Of these 37 units, 35 (95%)
indicated that they would be willing to participate in a future RCT.
Participant screening and recruitment
As of 29 February 2012, the proposed end of the recruitment period, 183 children had been screened out
of an expected 240. Of those screened, 117 (64%) were eligible (expected 228 or 95%) and 29 (25% of
eligible) children were recruited [expected 144 (64% of eligible)].
At the TSC meeting on 18 October 2011, the slow pace of recruitment was identified, and it was agreed
to make an application for a no-cost extension, to extend recruitment to 31 May 2012, in order to see if
strategies to improve recruitment had been effective. This request was granted.
Between 29 February 2012 and 31 May 2012, a further 48 children were screened, of whom 24 (50%)
were eligible and 20 (83% of eligible) were recruited. Although this population includes a number of
children who were either rescreened for eligibility, or whose parents had expressed a provisional interest in
the trial, and was therefore an enriched population in terms of potential recruits, it does indicate that the
strategies adopted by the study team to improve recruitment had a significant effect.
In total therefore, by 31 May 2012, 231 children had been screened (expected 240), 138 (60%) of whom
were eligible (expected 228: 95%) and 49 (35% of eligible children) were recruited (expected 144: 64%
of eligible: Figure 3).
Eligibility
Many more children than predicted did not fulfil the eligibility criteria for the study (10/240 predicted
vs. 93/231 observed). Reasons for non-eligibility were determined for 87/93 (94%) and can be
summarised as:
l severity of X(T) insufficient to meet eligibility criteria, 40%
l inability to demonstrate binocular vision at near fixation, 23%
l did not have target condition, 19.5%
l ocular comorbidity, 7%
l could not be adequately assessed, 4.5%
l received previous treatment, 3.5%
l systemic comorbidity, 2%.
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The most common reason for children not to meet the eligibility criteria was that their strabismus
was not sufficiently severe. This was either a reflection of the size of the misalignment when present
(a misalignment of 15 PDs was chosen to reflect usual criteria for surgical intervention) or that the
control of the strabismus (the ease with which the eyes were realigned following dissociation) was
too good.
Consent to participation in the trial
Brief information on reasons why eligible parents refused participation was available from the screening
logs in 80/89 (90%) cases.
These can be summarised as:
l parents did not feel strabismus severe enough to warrant surgery, 65%
l parents felt surgery was necessary and did not want to wait, 15%
l objections to trial processes, for example randomisation, 12.5%
l other reasons, 7.5%.
Reasons for agreeing to, or declining, participation in the trial were explored in more detail in the
qualitative interviews.
Participation bias
Consent was obtained from 56/89 (63%) ‘eligible not recruited’ (ENR) patients to record baseline and
9-month follow-up clinical data. The demographic and clinical characteristics of the ENR group were
compared with those who agreed participation in the SamExo trial (Table 5). Those who agreed to take
part had poorer control of their exotropia (as assessed by the NCS61) than those who declined; although
statistically significant this difference is unlikely to be clinically significant. The mean age of those who
agreed was slightly older but not significantly so (see Table 5). The proportion of males and females was
almost identical in each arm (34–37% male).
Randomisation
The randomisation process was generally smooth, although it was intermittently difficult to access the
website. This problem was generally solved through contact with the database team, although occasionally
the result of randomisation had to be given to the parents after they had left the clinic.
Randomisation appeared to work well, with 25 participants allocated to surgery and 24 to active
monitoring. One parent immediately declined the allocation to surgery, but the remaining 48 participants
remained in their allocated group.
Seven children in the active monitoring group, and four in the surgery group, were prescribed glasses at
baseline to correct refractive error. No glasses were issued subsequently.
Baseline demographic and clinical characteristics by treatment arm are provided in Table 6; there were no
significant differences on any parameter.
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TABLE 6 SamExo baseline demographic and clinical data by treatment arm (based on intention-to-treat analysis)
Active monitoring Surgery
Mean (SD) age, years (n= 49) 4.3 (2.2) 4.5 (2.3)
Female gender (n= 49) 14 (58%) 17 (68%)
Median (IQR) near stereoacuity (seconds of arc) (n= 40) 100 (60 to 800) 100 (60 to 400)
Overcome a base-out prisma (n= 9) 5/5= yes 4/4= yes
Mean (SD) VA (n= 47)b
Right eye 0.078 (0.11) 0.057 (0.09)
Left eye 0.072 (0.12) 0.054 (0.08)
‘Worse’ eye 0.088 (0.11) 0.070 (0.08)
Median angle (PD) (n= 49)
Near 16 (12 to 25) 20 (11 to 25)
Distance 30 (25 to 35) 30 (27.5 to 40)
Median control score (n= 49)
Total NCS61 5.5 (4 to 6) 5 (4 to 6)
Home control 2 (1 to 3) 2 (1 to 2)
Clinic control 3 (3 to 4) 3 (3 to 4)
Mayo score19 4 (3 to 4.75) 4 (3 to 5)
SD, standard deviation.
a Tested when child too young (< 3 years) to understand stereoacuity test.
b Uniocular testing was not possible for two children (VA with both eyes open: 0.100 and 0.200).
TABLE 5 Participation bias
Characteristics at screening
Agreed trial
participation
(n= 49)
Refused trial
participation
(n= 56) p-value
Median (IQR), NCS61 5 (4–6) 4 (4–5) p= 0.002a
Mean (SD), NCS61 5.3 (1.6) 4.4 (1.1) p= 0.001b (95% CIs 0.37 to 1.44)
Mean (SD) age, years 4.4 (2.2) 3.8 (2.0) p= 0.16b (95% CIs –0.24 to 1.42)
% male 37% 34% p= 0.76c [difference between groups= 7.2%
(95% CI –42.9% to 57.4%) or RR= 1.08
(95% CI –0.59 to 1.89)]
IQR, interquartile range; RR, relative risk; SD, standard deviation.
a Mann–Whitney U-test.
b Independent samples t-test.
c Chi-squared test.
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Adherence to protocol and retention
Two patients received surgery after the proposed 3-month window: one who was awaiting the results of
sickle cell investigations and one whose operation was arranged but then cancelled due to chickenpox.
The outcome results for these patients were included in the analysis even although only 4 months’
postoperative follow-up was possible, as opposed to the desired 6 months.
The parent of one patient allocated to surgery immediately declined the allocation. The participant was
retained in the trial and the results were analysed on an intention-to-treat basis.
Two patients in the active monitoring group were lost to follow-up despite repeated postal and
telephone reminders.
A total of 47/49 (96%) recruited participants attended for the final appointment, scheduled at 9 months
post randomisation.
The flow of participants through the trial is shown in the CONSORT (Consolidated Standards of Reporting
Trials) diagram (Figure 4).
Assessed for eligibility
(n = 231)
Excluded (n = 182)
Lost to follow-up (n = 0)
Discontinued intervention (n = 0) 
Allocated to surgery (n = 25)
Received allocated intervention (n = 24)
Did not receive allocated intervention (n = 1)
Reason: parent declined allocation 
Lost to follow-up (n = 2)
Reason: did not attend appointments
Discontinued intervention (n = 0)
Allocated to observation (n = 24)
Received allocated intervention (n = 24)
Did not receive allocated intervention (n = 0)
Randomised
(n = 49) 
  Eligible but refused
Excluded (n = 89)
Not eligible
(n = 93)
Baseline data (n = 56)
9-month data (n = 49)
Lost to follow-up (n = 28)
Declined (n = 5)
Analysed (n = 22)
Excluded from analysis (n = 0) 
Analysed (n = 25)
Excluded from analysis (n = 0)
FIGURE 4 Consolidated Standards of Reporting Trials diagram.
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Adverse events
Unexpected adverse events
There were no serious unexpected adverse events.
Expected adverse events
Active monitoring group
Although using our pre-defined definition no children in the active monitoring arm developed a constant
exotropia two (10301 and 46701) appeared to show some reduction in control and/or binocular function
as assessed by stereo acuity angle and NCS.
Surgery group
Two children had constant overcorrections following surgery at the outcome visit (10103, 23101); a further
five children (10401, 10406, 10408 and 22201, 45501) had intermittent overcorrections at either near
or distance fixation at outcome. One child (22103) underwent further eye muscle surgery for an
overcorrection within the follow-up period; this child developed a recurrent X(T) following repeat surgery.
In a future full trial consideration would be given to including development of amblyopia and loss of
binocular functions as expected adverse events.
Masking
Masking was successfully maintained throughout, in that there were no overt breaches. In the majority of
cases, however, the orthoptist assessing outcome correctly guessed which treatment arm the participant
was in, except for one case in the surgery arm and two in the active monitoring arm.
RESULTS
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Quality-of-life outcomes: Intermittent Exotropia Quality of
Life Questionnaires
No parent or child refused to complete this instrument. There were 49 out of 49 expected parent IXTQs at
baseline, 45 out of 46 expected proxy IXTQs (one was not administered, in error; the child in the other
three cases was too young, i.e. < 2 years) and 23 out of 23 expected child IXTQs (the remainder were not
old enough to complete an IXTQ themselves). At follow-up there were 45 out of 47 expected parent IXTQs
(two were not administered in error; the remaining two withdrew/were lost to follow-up), 44 out of 47
expected proxy IXTQs (three were not administered, in error; two withdrew/were lost to follow-up) and
29 out of 30 expected child IXTQs (one not administered, in error, and 17 were too young; the remaining
two withdrew/were lost to follow-up).
Missing response rates to individual items within the IXTQ were no > 7%. The highest percentage of
missing responses was for item 7 on the child-rated IXTQ (‘Does it bother you that you have to shut
one eye when it is sunny?’): this was unanswered by 1 out of 23 (4%) of children at baseline and 2 out of
29 (7%) at follow-up. All other items on the child-rated IXTQ were completed 100%. Items 1, 4, 9 and 11
on the proxy-rated IXTQ were missed in 1 out of 45 (2%) cases at baseline; at follow-up, items 3, 5, 7, 9
and 12 were each unanswered in 1 out of 44 (2%) cases. No items were skipped on the parent IXTQ at
baseline, and at follow-up items 4, 5 and 15 were missed in only 1 out of 45 (2%) cases.
Higher scores denote better perceived quality of life. At baseline, there were no differences between
treatment arm and IXTQ scores on any scale or subscale. There were no statistically significant changes
over time in the active monitoring group on any parent IXTQ scales. Significant improvements were found
within the surgery arm on all Parent IXTQ scales (total score, and function, psychosocial and surgery
subscales, Tables 7 and 8). Mean score on the Proxy IXTQ deteriorated for those in the active monitoring
arm and improved for those in the surgery group, but the differences were small and not or only just
statistically significant (Table 9). A small, but not statistically significant, improvement was seen in the Child
IXTQ scores for each arm (also note the very small numbers) but there was no significant difference
between groups (Table 10).
TABLE 7 Quality-of-life scores using IXTQs: mean (standard deviation), total score
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 20) 53.1 (15.9) 48.4 (22.9) –4.7 –14.1 to 4.7; 0.31
Surgery (n= 25) 51.9 (18.11) 74.3 (18.0) 22.4 10.7 to 34.0; 0.001
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Subscale quality-of-life scores
TABLE 8a Mean (standard deviation), function subscale score
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 20) 55.9 (18.4) 51.3 (25.6) –4.6 –13.5 to 4.3; 0.29
Surgery (n= 25) 51.6 (21.1) 74.5 (18.0) 22.9 11.3 to 34.4; < 0.001
TABLE 8b Mean (standard deviation), psychosocial subscale score
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 20) 52.3 (20.6) 48.4 (27.2) –3.9 –15.3 to 7.4; 0.48
Surgery (n= 25) 54.0 (20.9) 75.5 (19.4) 21.5 8.6 to 34.4; 0.002
TABLE 8c Mean (standard deviation), surgery subscale score
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 20) 40.0 (24.5) 36.9 (26.7) –3.1 –14.7 to 8.4; 0.58
Surgery (n= 25) 46.0 (24.9) 69.5 (24.8) 23.5 10.2 to 36.8; 0.001
TABLE 9 Mean (standard deviation), proxy IXTQ score
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 18) 77.7 (21.2) 69.5 (23.9) –8.2 –16.9 to 0.5; 0.064
Surgery (n= 23) 80.9 (14.5) 87.4 (12.8) 6.5 0.21 to 12.9; 0.043
TABLE 10 Mean (standard deviation), child’s IXTQ scorea
Group Baseline Outcome Mean change 95% CIs; p-value
Active monitoring (n= 12) 73.6 (19.8) 80.7 (13.5) 7.1 –5.1 to 19.4; 0.23
Surgery (n= 11) 73.1 (16.4) 76.5 (19.7) 3.4 –5.5 to 12.3; 0.42
a The 5- to 7-year-old and 8+-year-old versions combined; response categories reduced to 3 in the older age group as
recommended by IXTQ developers.66
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Clinical outcomes
Details of the clinical outcomes are provided in Table 11a–d, below.
In a pilot trial of this nature, which was not set up to provide definitive clinical information about the
effectiveness of treatment and was conducted over a short period of follow-up, it would be inappropriate
to draw definitive conclusions from a comparison of the clinical outcomes between the intervention and
active monitoring arms. Nevertheless, these data are of interest, and one of the primary outcomes of the
pilot trial was stated to be a comparison of children achieving a control score (NCS61) of zero between
the two groups.
Following discussion at the TSC on 19 June 2012, it was agreed that children who had well controlled
overcorrections (esophorias or intermittent esotropias), and in whom measurements of stereoscopic vision
had not deteriorated, would be classified as having a clinic control score of zero. Children with constant
esotropias following surgery cannot be classified using the NCS61 [which is designed only for the
assessment of X(T)] and are referred to as overcorrections.
The management of, and handling of data in relation to, children who developed overcorrections
following surgery requires further thought in a future study, with improved standardisation of the
management of overcorrections. We think it is reasonable to classify children who have intermittent
overcorrections, but have retained near stereo, as a good result but this approach needs to be considered
alongside QoL data.
Achievement of a score of zero on the NCS61 requires both that the parents never notice the strabismus
(NCS61 home= 0), and that on clinical testing, any deviation is immediately controlled (NCS61 clinic= 0).
The strabismus could therefore be regarded as ‘cured’ at this point, however this might not remain the
case over the longer term.
Furthermore, this criterion ignores any improvement that might be generated clinically, or in terms of QoL,
by improvement, rather than cure, of X(T). As we have seen, however, QoL gains were seen only in
relation to parental, rather than perceived or actual child QoL. Although numbers were small, analysis of
the QoL data by outcome group indicates that QoL gains were actually greatest in the group for which the
control score was improved but not zero (‘cured’), suggesting that ‘cure’, as defined by NCS61= 0, may not
necessarily be the most appropriate outcome measure for a full trial.
It is also known that ‘control’ of strabismus varies from day to day, and this may also be the case for
children with a clinic control score of zero. For these reasons, other potential outcome measures were
assessed to judge their applicability for further studies.
Measures of control of intermittent exotropia
Newcastle Control Score
In the active monitoring arm, no child had a NCS61 of 0 at the outcome visit (9 months from
recruitment). In 11, the score had worsened (by 1 or 2 points in 10), and in nine it had improved
(by 1 or 2 points in seven). In two patients, the score was unchanged. Generally, a change in score of
≤ 2 on this instrument would not be regarded as clinically significant. In summary, there was little
significant change in control scores over the follow-up period in this group.
In the surgery arm, nine children had a score of 0 at the outcome visit, four of whom had latent or
intermittently manifest convergent deviations but with retained or improved stereoacuity.
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In 18 children the score was improved: by 1 or 2 points in four, and by > 2 points in 14. In two children
there was no change in score, two deteriorated (by 1 or 2 points only) and three were overcorrected.
In summary, there were significant changes in this measure of control in the surgical group. The difference
in cure rates between the surgery arm [36% (95% CI 18% to 57%)] and the monitoring arm (0%, 95% CI
0% to 15%) was statistically significant (Fisher’s exact test; p= 0.002; difference= 36%, 95% CI 12.4%
to 59.5%).
On the measure of a satisfactory NCS61 outcome which we have previously reported (NCS61 ≤ 2 or
improvement ≥ 3), 2 out of 22 children achieved this outcome in the active monitoring arm, compared
with 15 out of 25 in the surgery arm. The difference in satisfactory NCS61 outcome rates between the
surgery arm and the active monitoring arm was statistically significant (60% vs. 9%, χ2 test; p< 0.001;
odds ratio 15.0, 95% CI 2.9 to 78.9).
Mayo control score
We also used the scoring system19 for control of X(T) devised by the group at the Mayo Clinic.18 This is a
10-point scale, based on the presence of exotropia either before or after dissociation of the eyes as
determined by a cover test, with timing of recovery of binocular fixation. Five points each are awarded for
control at distance and near fixation.
On this instrument, in the active monitoring group, 16 out of 22 children had a score at outcome within
± 1 point of baseline. Two patients improved by ≥ 2 points (3 and 4 points, respectively), and four
deteriorated by ≥ 2 points (two patients by 2 points and one patient by 4 points).
In summary, 72% of patients in the active monitoring arm showed no significant change in control using
this instrument.
In the surgery group, the Mayo control score19 at outcome was within ± 1 point of the baseline score in
eight children, was worse by 2 points in one child, was improved by ≥ 2 points in 13 children, and three
were overcorrected.
In summary, 52% of children in the surgery arm showed significant improvement in their control using
this instrument.
Measures of ocular alignment
Ocular misalignment is measured clinically by determining the size of prism which, when placed in front of
a misaligned eye, abolishes the corrective fixation movement that would otherwise result when the fixing
eye is covered. Differences of ≤ 10 PD are generally regarded as within the limits of measurement error,
and not considered clinically significant.67
Measurements of distance misalignment showed that, in the active monitoring arm, four children
had improvements of > 10 PD between baseline and follow-up, none had deteriorated, and 18 had
measurements at outcome within 10 PD of the baseline measurement.
Measures of distance alignment in the surgery arm showed that 13 children had improvements of > 10 PD,
four had intermittent overcorrections, two had constant overcorrections, none had deteriorated and six
had measurements within 10 PD of baseline.
In summary, there were significant improvements in distance alignment in 18% of the active monitoring
arm and 52% of the surgery arm.
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Measurements of near misalignment showed that, in the active monitoring group, three children had
improvements of > 10 PD, one child deteriorated by > 10 PD and 18 had measurements at outcome within
10 PD of baseline.
Measures of near misalignment in the surgery arm showed five children had improvements of > 10 PD,
two children deteriorated by > 10 PD, 10 had measurements within 10 PD of baseline, five were
intermittently overcorrected and three had a constant overcorrections.
In summary, there were significant improvements in near alignment in 14% of the active monitoring arm
and 20% of the surgery arm. Of the surgery arm, 32% showed either intermittent or constant
overcorrections at near fixation at 6 months postoperatively.
Binocular vision and stereoacuity
A change of two octaves of stereoacuity is generally considered to be clinically significant.
At outcome in the active monitoring arm, of 19 children who could complete near stereoacuity testing at
near fixation, two had deteriorated by two or more octaves, nine were within two octaves and eight had
improved by two octaves. Of the remaining three, who were too young to perform stereoacuity testing
and whose binocular vision was assessed using their ability to demonstrate a fixation movement in
response to a prism placed before one eye, two were stable and one had deteriorated.
In summary, the binocular vision of 86% of children in the active monitoring arm was either stable or
improved over the follow-up period, and significantly deteriorated in 14%.
In the surgery arm, near stereoacuity deteriorated by more than two octaves in four children, remained
within two octaves in 15, and improved by more than two octaves in four. Of two children assessed using
prisms, one was stable and one had deteriorated.
In summary, the binocular vision of 80% of children in the surgery arm was either stable or improved, and
significantly deteriorated in 20% over the follow-up period.
Eligible not recruited outcome data
Follow-up data were obtained for 49 out of 56 (88%) of the ENR patients who consented to data
collection and storage. Mean duration between screening and follow-up was 9.4± 2 months,
range 4–15 months. In most cases (n= 34), the follow-up data were collected within 10 months from
screening. In 12 cases, review was between 11 to 12 months and in 3 cases it was beyond a year
from screening (2 at 13 and one at 15 months). However, any treatment reported was received within
9 months from screening; a few were already having treatment for vision prior to screening as indicated
in Table 12.
Details of primary and secondary clinical outcomes for ENR patients are provided in Tables 13 and 14.
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TABLE 12 Interventions in ENR patients
ENR interventions within 9 months from screening n %
None 31 63.3
Minus lenses for control 4 8.2
Surgery 7 14.3
Glasses for vision (prior to screening) 5 10.2
Glasses for vision (at or after screening) 1 2.0
Occlusion for amblyopia 1 2.0
Total 49 100.0
TABLE 13 Primary outcome for ENR patients
NCS60= 0 at follow-upa
Treatment within 9 months
None Conservative Surgery
Yes 0 (0%) 1 (9%) 4 (57%)b
No 27 (100%) 10 (91%) 3 (43%)
a Total NCS61 missing in four cases, as home control score was not available.
b Two esophoria/esotropia recoded to NCS61= 0.
TABLE 14 Secondary outcome: satisfactory NCS61 for ENR patients
NCS61 satisfactorya at follow-up?b
Treatment within 9 months
None Conservative Surgery
Yes 1 (4%) 3 (27%) 7 (100%)c
No 26 (96%) 8 (73%) 0 (100%)
a NCS61 0–2 or improved by ≥ 3.
b Total NCS61 missing in four cases, as home control score was not available.
c Two with esophoria/esotropia recoded to NCS of 0.61
RESULTS
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Chapter 5 Economic analysis
This section presents findings from the health economics component of the pilot study to test thefeasibility of a RCT comparing eye muscle surgery against active monitoring for childhood intermittent
distance exotropia.
The main aim of the health economics component was to rehearse the methods of data collection and so
inform the development of the economic evaluation for a definitive study. We evaluated the ease of data
collection (response rate and data completeness) of the different sources, including the case report form
(CRF), reference costs documentations and Participant Costs Questionnaires (HSUQ and TTQ).
Collection of data
Data were collected on effects and costs for both study arms. Sources of data collection are shown in the
tables in Appendix 8.
Outcome data
Over 50% of the participants were < 5 years old and none of the existing standard QoL instruments used
to estimate a utility score is validated for use among children in this age group, hence they were judged to
be inappropriate for this study. As an alternative the IXTQ was adopted as a QoL outcome. However, this
tool cannot be used to estimate preference-based utility measures, so it is not ideal for incorporation into
a cost–utility analysis. Clinical outcomes are obtained and recorded in the CRF. All of those outcomes are
collected at baseline and at the final follow-up.
Cost data on the intervention
The main cost is related to the eye muscle surgery in the treatment arm. Surgery-related costs include
costs of staff, consumables, capital and overheads, as well as costs due to postoperative complications.
Staff costs, overheads and any costs related with postoperative complications. These can be calculated
based on the following information recorded on the CRF for every participant in the study:
l grade of operator
l grade of anaesthetist
l grade of assistant staff
l time of patient entry into and leaving operating room
l time of patient entry into and leaving recovery room
l date of admission and discharge
l postoperative complication.
To calculate total costs of the surgery, data on the use of consumable and reusable equipment required for
the surgery would be collected from each participating centre. These data would be collected in a parallel
data collection exercise to the participant-level data collection gathered within the trial. This work was not
conducted as part of the pilot as the quantities and unit costs are likely to vary between the current pilot
study and the end of the definitive study. In addition, the methods required to elicit these costs are well
established and hence do not need to be tested as part of this pilot study.
Cost data on the use of NHS health services and patients
out-of-pocket expenses
The perspective adopted was that of the NHS and patient. The Participant Costs Questionnaires (HUSQ and
TTQ) were designed and piloted to collect information on NHS resource use and patients’ out-of-pocket
expenses, as well as the cost of travelling to access care and the time that this takes. As all of the patients
were children aged < 12 years, the Participant Costs Questionnaires were completed by their parents.
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The Participant Costs Questionnaire was designed to be as extensive as possible and to collect sufficient
information but, at the same time, not to over burden the participants. It has two parts: HSUQ (Part A)
records information on the level of usage of the health services and the costs of any other self-purchased
health care required to manage the condition, and TTQ (Part B) collects information on the time and travel
costs of the participants attending each possible type of NHS services. The role of TTQ is to inform the
calculation of unit costs of the participants to attend each type of health services, and this will then be
combined with the information obtained from HSUQ to derive total costs to the NHS and the patients.
Participants’ self-report data become increasingly unreliable as the period of recall increases.68 In the pilot
study, HSUQ was administered, after surgery, at 2 weeks, 3 months and 6 months for the treatment
group, and at 3, 6 and 9 months after randomisation for the control group (considering that it may take
up to 3 months for participants in the treatment group to receive surgery) in order to minimise recall bias.
As TTQ is used to obtain unit costs, it is necessary to collect it only once, hence it was administered at
3 months from randomisation for the control group and at 3 months after surgery for the
treatment group.
In HSUQ the data on NHS resources collected included the use of both secondary and primary care related
to the patient’s condition. The use of secondary care services includes non-protocol (protocol visits are
those scheduled for the purposes of data collection) outpatient visits and hospital admissions. The use of
primary care services includes prescription medications and contacts with primary care practitioners
(e.g. GPs, practice nurses and optometrists).
Participant costs comprise three elements: for TTQ, travel costs for accessing NHS primary and secondary
care, and time costs of travelling and attending NHS primary and secondary care; and for HSUQ,
self-purchased health care and related management costs. The estimation of travel costs requires
information from participants about the number of visits to health-care services (collected in HSUQ), and
the unit cost of making a single journey to each type of health-care provider (derived from information in
TTQ). The parents of the child are asked, in TTQ, for each type of visit, the mode of transport they used
and the fare for one way if they travelled by bus, taxi or train, or the number of miles they travelled and
parking fees if they used a private car. Participants’ time costs are collected in a similar manner. The
parents of the child are asked how long on average they spent travelling to and attending each type of
health-care provider. They are also asked what activity they would have been undertaking (e.g. paid work,
leisure, housework in the case of parents or carer) had they not accompanied their child to attend the
health-care provider. These data are presented in their natural units, for example hours and minutes, and
attached to monetary value using standard economic conventions, for example the Department of
Transport69 estimates for the value of leisure time. Self-purchased health care includes over-the-counter
medications (e.g. eye drops). Private health insurance cost is included if the insurance is purchased for
the patient’s eye conditions. Management cost includes parents’ time costs if they are absent from work
in order to look after the child due to their eye condition.
Data collection results
As described in the previous section, there are 49 patients in total recruited to this trial, with 24 randomised
to the control arm and 25 in the treatment arm; however, one of the patients in the treatment arm
changed their mind and asked to be switched to the control arm, so as a result 24 patients in the treatment
arm received surgery and 25 patients in the control arm were monitored only of their progress
without surgery.
Outcome data
The outcome data collected on the QoL of the patients and their parents have been reported in the QoL
results chapter (see Chapter 4), and as we will not be conducting a cost-effectiveness analysis, we do not
include this in this chapter.
ECONOMIC ANALYSIS
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Data on surgery costs
The completion rate relating to the surgery information on the CRF was extremely high with 100% of core
information obtained, including admission and discharge dates, grades of surgeons, and time in and out
of the operating theatre. There is a very small number of missing data on the grades of assisting staff,
grades of anaesthetists, and time in and out of the recovery room. All of the 24 patients in the treatment
arm were admitted as day cases for the surgery. None reported postoperative complications. The vast
majority of the participants (96%) were operated on by a consultant (Table 15), with various grades of
staff assisting the surgery (Table 16). There are, however, five patients (21%) for whom there is no
recorded information on grade of assisting staff but it is unclear whether these data are truly missing or
missing because there was no assistant present. Similarly, the majority of the patients (97%) were given
anaesthetic by a consultant (Table 17). Only one participant (4%) had no information on the grade of
anaesthetist recorded.
Based on the information provided on the time in and out of the operating theatre, we calculated the
duration of operating time for each participant. The mean operation time was 47 minutes, ranging from
31 minutes to 65 minutes. For the duration of time spent in the recovery room, recorded on the CRF, data
were missing for three (13%) participants. The mean time patients spent in the recovery room after
surgery is 36 minutes and ranges from 19 to 75 minutes (Table 18).
TABLE 16 Grade of assistant
Grade Observations % based only on recorded data (n= 19) % based on total (n= 24)
Training fellow 8 42.11 33.33
Senior house officer 2 10.53 8.33
Registrar 8 42.11 33.33
Consultant 1 5.26 4.17
Total recorded 19 – 79.20
Missing 5 – 20.80
Total 24 – 100.00
TABLE 15 Grade of operator
Grade Observations %
Training fellow 1 4.17
Consultant 23 95.83
Total 24 100.00
TABLE 17 Grade of anaesthetist
Grad Observations % based on only recorded data (n= 23) % based on total (n= 24)
Registrar 1 4.35 4.17
Consultant 22 95.65 91.67
Total recorded 23 – 95.80
Missing 1 – 4.20
Total 24 – 100.00
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Participant costs and use of services data
Overall, the response rates for the HSUQ and TTQ have exceeded our expectations (Table 19). For the
treatment arm, an average response rate of 97.2% was achieved. For the control arm, the response rate
was slightly lower at 84%, which is still much higher than a typical survey response rate in clinical trials
of around 50–70%.70 The high response rate achieved is likely to be because the HSUQ and TTQ were
completed on scheduled protocol visits, with participants assisted by a member of the research team.
It is not surprising that the response rate in the treatment arm is higher than the control arm, as
participants had more engagement with the trial because a physical intervention is carried out.
Among respondents to the HSUQ and TTQ there were a small number of respondents who did not answer
some relevant cases. These missing data can result from a number of reasons, including data input errors,
respondents refusing to answer certain questions, respondents’ errors, and questions that were unclear
for respondents. For the last three potential reasons for missing data such problems may be alleviated by
improving the design of the questionnaires, and, indeed, one of the aims of this pilot study is to test and
refine data collection tools and this is returned to below (see Identification of data collection and entry
issues with the questionnaire).
Table 20 summarises the health service use collected from the HSUQ (Part A of the Participant Costs
Questionnaire), and Table 21 presents patients’ time and travel costs of attending each type of health
services collected from the TTQ (Part B). Data collected in this pilot trial can also provide us with
information on the pattern of patients’ use of health services, which will be helpful in designing how the
relevant data should be collected in the definitive trial. Based on Table 20, on information from the HSUQ,
it seems that majority of the service use is concentrated within the time frame of the second follow-up.
There is more use of secondary services in the treatment arm than in the control arm, which is not
surprising. However, the reported numbers of hospital admissions at the first follow-up time point in the
treatment arm may not be an accurate reflection of the service use as a result of the intervention. This may
be due to confusion by some patients who may have included their initial surgery as an admission on the
Participant Costs Questionnaire despite instructions not to do so (we return to this issue below). This also
applies to the prescription medication where they may have also included those that have been prescribed
at the hospital following the intervention rather than any additional prescription after the intervention.
There appears to be very little use of health services in the control arm overall and very few use of health
services in the treatment arm at the third follow-up. Consideration will be given whether or not costs data
collection can be restricted to the initial 6 months from randomisation except for critical events (e.g. new
or re-interventions) which would also be of interest as a clinical outcome. The TTQ aims to estimate the
average costs of patients attending each type of health services. The costs include travel costs as well as
time costs of the patients and their accompanying person. With the information recorded, we can
TABLE 19 Participant costs questionnaire: response rate
Response rate Control arm (n= 25) Treatment arm (n= 24)
Follow-up 1 92% (23/25) 100% (24/24)
2 76% (19/25) 96% (23/24)
3 84% (21/25) 96% (23/24)
Average 84% 97%
TABLE 18 Time spent in theatre and recovery room
Time Observations Mean (minutes) SD Minimum Maximum
Length of operation 24 (100%) 47.2 9.6 31 65
Length in recovery room 21 (87.5%) 36.4 14.4 19 75
SD, standard deviation.
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TABLE 21 Participant costs questionnaire (TTQ): summarya
Cost items collected
Control arm, 3 months after
randomisation (25 participants;
23 questionnaires received)
Treatment arm, 3 months post
operation (24 participants;
23 questionnaires received)
Hospital
admission
Form of transport (taxi) × 1, (car) × 2, (bus) × 1 (bus) × 1, (train) × 1, (car) × 5
Cost of fares (2.2) × 1, (0) × 1, (15) × 1 (4.2) × 1, (7) × 1
Miles by car one way (10) × 1, (3) × 1 (3) × 1, (6) × 1, (7) × 1, (9) × 1,
(10) × 1
Parking fee (8) × 1, (1.5) × 1 ((1.5) × 1, (3) × 1, (4) × 1, (8) × 1,
(8.5) × 1
No. of nights (0) × 2, (0.5) × 1 (0.5) × 1, (1) × 5
Activity would be doing
otherwise
(paid work) × 2, (child care) × 1 (paid work) × 6, (child care) × 1
No. of hours off work (0) × 1, (4) × 1, (8) × 1 (5) × 1, (7) × 1, (9) × 1, (9.5) × 1,
(14) × 1, (50) × 1
Having another
accompanying adult
2 5
No. of visits while in hospital 0 (1) × 4
Outpatient
visits
Form of transport (bus) × 5, (train) × 1, (taxi) × 1,
(car) × 9, (walked) × 1
(bus) × 3, (train) × 1, (car) × 8
Cost of fare (1.8) × 1, (2.5) × 1, (15) × 1,
(26.5) × 1
(2.3) × 1, (3.7) × 1,
(4.2) × 1, (7) × 1
Miles by car one way (3) × 1, (5) × 2, (6) × 1, (8) × 1,
(10) × 2, (12) × 2, (15) × 1
(2) × 1, (3) × 1, (6) × 2, (7) × 1,
(8) × 1, (9) × 1, (10) × 1
Parking fee (1.5) × 1, (2.6) × 1, (3) × 1,
(3.1) × 1, (4.7) × 1, (6) × 1, (20) × 1
(1.5) × 2, (2.5) × 1,
(2.6) × 1, (3) × 2
Length of travel time (0.1) × 2, (0.15) × 2, (0.2) × 1,
(0.25) × 1, (0.3) × 1, (1) × 3,
(1.3) × 1, (2) × 1, (4) × 1, (15) × 2
(0.1) × 1, (0.2) × 3, (0.3) × 4,
(0.45) × 1, (10) × 1
Length of time spent
in hospital
(0.25) × 1, (0.3) × 2, (1) × 6,
(1.3) × 1, (2) × 1, (2.3) × 1, (3) × 1,
(4) × 1, (30) × 1, (45) × 1
(0.3) × 2, (1) × 5, (1.15) × 1,
(1.3) × 1, (2) × 1, (60) × 1
Activity would be doing
otherwise
(paid work) × 9, (housework) × 1,
(child care) × 2, (studying) × 1,
(other) × 1
(paid work) × 7, (housework) × 1,
(child care) × 1, (leisure) × 2,
(other) × 1
Having another
accompanying adult
8 5
GP/nurse visits Form of transport (bus) × 1, (car) × 1 (car) × 1
Cost of fare (1) × 1 0
Miles by car one way 0 (6) × 1
Parking fee 0 0
Length of travel time (0.1) × 1, (0.3) × 1 0
Length of time spent in
GP practice
(0.1) × 1, (0.3) × 1 0
Activity would be doing
otherwise
(1) × 2 0
Having another
accompanying adult
1 0
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calculate the typical costs for an individual to attend the health services, which will then be combined with
information collected on the HSUQ to derive a total costs for each individual’s out-of-pocket expenses.
These data would in the definitive study be presented as average costs for each item. These costs will
be estimated by multiplying the number of times each individual’s service use/days off by the number
of individuals, then sum them across individuals, which will then be divided by the total number of
respondents contributing data (examples are given in the footnote of Table 20). For this study, however,
the data within Tables 20 and 21 are presented in their raw form for easier interpretation of responses.
During the follow-up period, any further interventions (e.g. further surgery, BOTOX injection) are also
recoded on the CRF. This information is needed as those further interventions will have an impact on the
total costs. In this pilot study, there was only one patient who went through a further surgery and no
patients had BOTOX injection.
Identification of data collection and entry issues with
the questionnaire
Recording of hospital admissions
With respect to questionnaire design, a concern is the confusion of some participants as to whether or
not the hospital admission that forms part of the initial surgical intervention should be included when
answering questions on use of secondary health services. The response to this question on admission was
intended to include only additional admissions during the follow-up period, as details of the initial surgery
are already recorded on the CRF. Therefore, inclusion again would introduce an element of double
counting that would bias the evaluation against surgical intervention. The version of the questionnaire did
include an instruction not to include the initial hospital admission but this might not have been sufficiently
clear. For the full trial we will seek to collect information on hospitalisation on the CRF rather than by
participant-completed questionnaire to avoid any prospect of double counting. This will increase the
burden on researchers but will also reduce the response burden on participants.
We are not aware of any empirical work that has compared 3- and 6-month recall periods on the extent of
recall bias. In other studies, we do use a 6-month recall period but in this study we felt that the additional
TABLE 21 Participant costs questionnaire (TTQ): summarya (continued )
Cost items collected
Control arm, 3 months after
randomisation (25 participants;
23 questionnaires received)
Treatment arm, 3 months post
operation (24 participants;
23 questionnaires received)
Optician visits Form of transport (car) × 2 (car) × 1
Cost of fare 0 0
Miles by car one way (3) × 1, (15) × 1 (6) × 1
Parking fee (2) × 1, (4.7) × 1 0
Length of travel time (0.2) × 1, (0.4) × 1 (20) × 1
Length of time spend
at optician
(0.37) × 1, (0.45) × 1 0
Activity would be doing
otherwise
(paid work) × 1, (other) × 1 0
Having another
accompanying adult
2 0
a Numbers in the brackets represent the mode of transport/length of time (minutes/hours) distance travelled (miles)/costs paid (£)
for the relevant question answered, and the number following the ‘×’ symbol indicates the number of participants who have
given the respective answer.
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response burden on participants would be worth the additional accuracy gained from more frequent
administration of the questionnaires.
The CRF gives a more complete and accurate account of the event regarding hospitalisation; however,
we would consider, in a future study, asking all participants about ‘hospitalisation for eye surgery’, as
one explicit category and ‘hospitalisation for other reason’ as the next category. That would unblind
researchers but, as the randomisation of most was guessed correctly, this might not be an important issue.
We would also consider having two categories of hospitalisation in the Participant Costs Questionnaire.
Recording of the mode of transport
It appears that some participants had difficultly completing sections of the TTQ (Part B of the Participant
Costs Questionnaire) because they used multiple modes of transport to access care. To maintain an
appropriate balance between the level of details collected and the length of the questionnaire, we asked
participants to report only the mode of transport that made up the longest part of their journey, but
elsewhere we went on to ask the total monetary out-of-pocket costs incurred. This appears to confuse
some participants. Therefore, we for the definitive trial will reorganise the layout of the questions asked so
that they will become clearer.
Consistency of the coding of data during data entry
Common conventions need to be adopted to convert some participant answers on the time and monetary
values when entering data on to the database. The questionnaire was designed for the convenience of
respondents to report values in their natural units of hours and minutes (in the case of time) and in pounds
and pence (in the case of monetary values) but, at the data input stage, the lack of an agreed framework
to convert different units into one common unit leads to confusion and measurement error. Further
consideration is needed on how best to handle this in the data trial. Two potential solutions are the
development of a data entry manual describing how to respond to data recorded on the questionnaire in a
form different to the one intended. A second solution would be for all data to be entered as recorded on
the questionnaire and then have common conventions applied to the data at the data cleaning stage,
all of which can be formally documented. The former option may still allow variation between data entry
clerks to persist and the data entry manual would need revision throughout the study as novel issues arise.
The latter would allow clearer documentation of any changes but would require potentially problematic
data to be highlighted so that they can be investigated at the data-checking stage.
Summary
This section of the pilot study sought to investigate the feasibility of conducting an economic evaluation as
part of a RCT comparing eye muscle surgery against active monitoring for childhood intermittent distance
exotropia. Specifically, the health economic component of the study aims to assess the ease of health
economics data collection.
Costs data are collected from a number of sources. Information regarding the surgery is recorded on the
CRF, and services use following the intervention is collected through the Participant Costs Questionnaire,
which also gathers information on patients’ out-of-pocket expenses. Assessing both sources of data
collection, a > 80% completion rate was achieved. The high response rate of Participant Costs
Questionnaire may be due to the high level of commitment from the participants and the fact that
the questionnaires were completed on patients’ study visit. There are, however, some issues regarding
questionnaire design, which will require the tool to be refined for the definitive trial.
The use of health services appears to be concentrated within the first 6 months of the trial follow-up for both trial
arms. Consideration will be given for a definitive study streamlining the data collection and hence reducing the
burden to both the participants and the research team, and potentially also reducing the costs of research to the
funder. Overall, the work conducted has shown that it is feasible to collect meaningful health economics data in
a definitive trial, subject to adjustment of data collection points and refinement of the data collection tool.
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Chapter 6 Discussion
Trial management
The structures that were put in place to manage the trial appeared to be valuable in maintaining regular
contact between key stakeholders and ensuring efficiency. Telephone conferences were a useful
supplement to face-to-face meetings.
Screening and recruitment
Although screening rates were initially high, as patients had been identified in readiness for the opening
of recruitment, there was a lag in recruitment due to the delay in the subsequent appointment for the
recruitment clinic.
New referral letters often did not contain sufficient information to make a judgement about whether or
not the child had X(T), and many children referred with suspected X(T) did not have X(T) at all. This wasted
appointments in the screening clinics and meant that it would have been confusing to provide parents
with information about a trial for which their child might not be eligible, so it was decided to reserve
providing parents with information leaflets until the initial clinic visit.
Given the age of the children involved, it was not always possible to confirm eligibility for the trial at
the initial screening visit, and many children had to be reviewed before eligibility was confirmed. This
generated further appointments in the screening clinics, which blocked slots for other potentially
eligible children.
Subsequent blockage of appointment slots by children who needed rescreening for eligibility, and parents
who wished to take more time to consider recruitment when their child was eligible, contributed to a
failure to recruit to target. This was compounded by an unexpectedly high proportion of children who
failed to meet the eligibility criteria.
The most common reason for children failing to meet the eligibility criteria was that their strabismus was
not sufficiently severe: either the angle of misalignment was too small or their X(T) was too well controlled
to meet conventional criteria for surgery for X(T). The NCS61 grading for trial entry was defined as ≥ 3.
However, this score could be achieved by a parent who noticed X(T) all the time without any objective
evidence that X(T) was present. Although this was not the case for any trial participant, the criteria for trial
entry were on the limit of what would be considered an acceptable degree of severity of X(T) to justify
intervention, particularly in younger children.
Most surgeons would not be comfortable operating on a child whose X(T) was objectively well controlled.
Conventional surgical criteria suggest that a NCS61 of ≥ 2 should be present on distance fixation in order
for eye muscle surgery to be appropriate.18,20 This was not specified in the current study and should be in
a future trial.
On the other hand, many children in the active monitoring arm more than fulfilled conventional criteria for
surgical treatment, and, by and large, did not deteriorate significantly, with many showing some evidence
of spontaneous improvement, particularly in stereoacuity, over the follow-up period.
In a longer duration study, it is uncertain what proportion of parents would be happy to defer intervention
for a prolonged period.
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Recruitment of children who had failed school vision screening because of X(T) enriched the population
of children referred with X(T), but also targeted a group of children whose parents had not presented
their children for treatment and who, by implication, were less concerned to have the strabismus treated.
It also introduced an age bias to the participants, as those who were recruited from school screening were
between 4 and 5 years of age.
For parents and clinicians, the initial screening appointment presented a challenge, in that it had to
encompass a diagnosis of the child’s eye condition, an assessment of eligibility for the trial, an explanation
of possible treatment options, an explanation of the lack of robust evidence underpinning the timing and
effectiveness of these interventions, and an explanation of the trial. It was rarely possible to cover all of
these points in a single consultation, not least because of the amount of new information that had to be
assimilated by the parents, and the questions they had about treatment and the trial, were often not
answerable in the subsequent telephone call. There were also difficulties in contacting many parents by
telephone during the working day, and attempts had to be made to contact them outside of normal
working hours, which were not always successful.
Furthermore, the explanation of the lack of evidence underlying the effectiveness and timing of
intervention served, in many cases, to undermine the parent’s confidence in the treating clinician, and by
extension, the trial.
In Newcastle, a research nurse was recruited during the screening and recruitment phase of the trial, and
she subsequently gave most of the information about the trial itself. This separation of the role of the
treating clinician from the main recruiter to the trial proved extremely beneficial in aiding the process of
recruitment. Such use of research nurses in all centres should be considered in a future study.
It became apparent during the process of recruitment that the initial two visits, for screening and
recruitment, and the intervening telephone call, often gave insufficient time for parents to fully consider
participation in the trial. Many parents wished to observe the progress of the condition before considering
treatment, and many were concerned at the prospect of surgery. This often generated further
appointments in the recruitment clinics, which blocked further slots for potential recruits.
Some parents had concerns about trial processes, particularly randomisation.
During the screening and recruitment phase, it was decided to not only restrict entry to the trial to newly
diagnosed children, but also to provide study information to children who had a recent confirmed
diagnosis of X(T) and had not received any treatment, at all sites. These children were then allocated
appointments for recruitment clinics if their parents expressed an interest in participating in the trial.
Despite the difficulties outlined above, it is important to state that the rate of refusal of eligible children
to participate was similar to that predicted in the initial submission. It was predicted that the refusal to
participate rate would be around 33% – in fact, 64% (89/138) of eligible children identified refused
to participate.
In summary, the strategies adopted to improve recruitment included improving the efficiency of the
utilisation of screening clinic appointments by screening out children who did not have the condition,
recruitment of prevalent cases and cases from preschool screening, and the separation of recruitment from
clinical care by the use of a research nurse in one centre.
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Participation bias
For ethical reasons, it was possible to collect limited information only on children who were eligible for,
but declined participation in, the trial. On the basis of the information available to us, there appeared to
be differences in age and strabismus control between those participating and those declining participation,
with those participating being older and having poorer control. Such differences, if truly present, might
affect the generalisability of a longer-term study. QoL was not measured in the group eligible but declining
participation, but, given the effect of intervention on parental anxiety, it is tempting to speculate that
those parents entering the trial were, on the whole, more anxious about their child’s condition than those
who declined participation.
Randomisation
No significant issues were identified in relation to randomisation, which appeared to provide groups that
were matched for baseline demographics and clinical severity.
Adherence to group allocation and protocol
There were minor issues in relation to the timing of surgery due to comorbidity.
Adherence to group allocation was excellent, with only one parent declining the allocated group. Adherence
to group allocation might be a more significant issue in a longer-term study. In particular, parents who were
in favour of surgery for their child’s X(T) would be unlikely to remain in an active monitoring arm in a
long-duration study.
Retention of participants for the duration of the study was generally excellent, and is a tribute to the
intensive attention paid to this by the study team at all sites.
Adverse events
The major identified risk for participants in the active monitoring arm of the study was that the condition
might have a deterioration in their clinical condition. It is challenging to distinguish a permanent
deterioration from fluctuation of the condition in this patient group.62,71,72 However, in spite of some
apparent deterioration in the clinical picture in two children (10301, 46701), none developed a
constant strabismus.
At outcome, two children in the surgery arm had constant esotropia at near and distance and were
classified as over corrected; a further child had surgery for an overcorrection within the follow-up period.
In addition, there were four children who had eso deviations for near viewing only, three of which
were intermittent and one that was constant. This is in line with previous studies25,26 and permanent
overcorrection with loss of stereoacuity remains the most significant complication of surgery. The
management of surgical overcorrection should be standardised in a future trial.
Maintaining masking
Although no breaches of the masking to group allocation of the orthoptists assessing outcome at each
centre were reported, in almost every case the orthoptist, when asked, correctly guessed the group
allocation. It is unlikely that, 6 months after surgery, traces of the surgical procedure itself were still visible,
as redness of the eyes following strabismus surgery generally lasts for a maximum of only 6 weeks.
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In cases of overcorrection, previous surgery would be assumed, as this is not an outcome that occurs
spontaneously. Similarly, there may well have been an assumption that cases which had changed little in
clinical appearance over the follow-up period were more likely to have been actively monitored. This effect
is likely to be lessened, but not abolished, in a study of longer duration.
Qualitative interviews
These indicated that a trial with a preference arm would be more acceptable to parents. In general, the
information provided to parents appeared to be of an acceptable standard, and was not a major barrier to
trial participation. The way in which the diagnosis and information about the trial was communicated did
appear to be an issue, indicating the need for a greater use of research nurses and training in future
studies. Some parents were keen to have more details of surgical success rates, indicating the need for
a definitive trial.
Quality of life
The IXTQ questionnaires showed no differences between groups for the child-reported questionnaire and
the proxy questionnaire, where the parents indicated the impact that they felt that X(T) had on their child.
There was a significant difference between the surgery group and active monitoring group for the parental
questionnaire, which was spread across all subscales. This portion of the IXTQ mainly enquires about
parental anxiety (see Appendix 5) – in fact, all of the questions in this section commence with either the
phrase ‘I worry . . .’ or ‘It worries me . . .’.
This suggests that the improvement seen on this instrument mainly reflects the effect of the intervention
on parental anxiety, either because ‘something has been done’ or because the effect of the
intervention on the condition has reduced parental anxiety, rather than that the child’s QoL has
improved, or even the parent’s estimation of the child’s QoL.
This does reflect current clinician experience, where, in the absence of robust evidence of the long-term
effectiveness of interventions for X(T), treatment is often driven by parental anxiety and anecdotal or
personal experience.
It was not possible to collect IXTQ data on parents of eligible children who did not consent to
participation, but it is interesting to speculate that there may have been a bias, with those parents
not consenting because they did not wish their child to have surgery being less anxious, and vice versa.
It would be interesting to investigate generic measures of anxiety in parents seeking surgery for their
child’s X(T) and those wishing to avoid it.
Clinical outcomes
There appeared to be variability in outcomes between the four centres, although the numbers involved
were too small for formal analysis. One potential improvement that could be made in a further trial would
be greater standardisation of the surgical procedure; however, it is likely that this would not completely
eliminate the variation in clinical outcomes. Furthermore, where standardisation – for example
photographic documentation with review by a reading centre – has been performed, variations in surgical
technique have persisted.
Strabismus control
The inclusion criteria for the study specified a NCS61 of ≥ 3. This figure was chosen to be in line with early
work on this instrument, which indicated that few children underwent surgery with scores of < 3.20,25,61,73
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The NCS61 is made up of three components: a home control score (1) that rates the proportion of time
that parents see the strabismus, and a clinic score that rates the ease of realignment at near (2) and
distance (3) following a cover test. Each portion of the score (home, clinic near and clinic distance)
contributes three points, giving a potential total of nine points.
It is possible to obtain a score of 3 from one of the components alone; however, in this study no child was
randomised without a home control score of ≥ 1 and a clinic control score of ≥ 2. This is likely to reflect
the minimum score at which parents and clinicians are prepared to randomise participants to a RCT
of surgery.
There were clear benefits on control from surgery in this study.
Although the NCS61 and the Mayo score19 appeared to correlate well (r= 0.88; p< 0.001), given that the
NCS61 incorporates a parent-reported outcome measure, and the difficulties of obtaining a Mayo score19
(which relies on a 30-second period of initial observation and timing to realignment), we would prefer to
use the NCS61 in a future trial, while recognising the possible variabilities of clinic control and the potential
unreliability of parental reporting.
Ocular alignment
In parallel with the benefits on control, there were clear benefits on ocular alignment from surgery. This
needs to be balanced by six participants who were permanently or intermittently ovecorrected at distance,
and one only overcorrected at near, at outcome, plus another participant who had further surgery for an
overcorrection within the follow-up period.
Four of these seven patients had retained or improved stereoacuity; however, some of these
overcorrections were cosmetically significant. Although initial overcorrection has been regarded as a good
prognostic indicator of long-term alignment after surgery for X(T)74,75 (although this has been disputed26,76),
overcorrection at 6 months following surgery may not resolve, and may require further treatment if
cosmetically significant or associated with a reduction in binocular vision or amblyopia.
In summary, there were significant improvements in near alignment in 14% of the active monitoring arm
and 20% of the surgery arm; 32% of the surgery arm showed either intermittent or constant
overcorrections at near fixation at 6 months postoperatively.
Binocular vision and stereoacuity
Although there were three participants whose binocular vision deteriorated in the active monitoring arm,
given the variability in current clinical testing of binocular vision in young children, the clinical significance
of this is unclear. The eight participants in whom stereoacuity improved could either be demonstrating a
maturational effect or a spontaneous improvement in their condition.
In the surgery arm, two of the participants who were overcorrected at both distance and near, and the
one who was overcorrected only at near, had a reduction in binocular vision and stereoacuity, and can
be classed as functional overcorrections. The binocular vision or stereoacuity of a further two children
deteriorated. These children were not overcorrected, but did show some evidence of deterioration of their
X(T). The other four children with intermittent overcorrections did not show any deterioration in
their binocular vision.
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Chapter 7 Conclusions
We have demonstrated that it is possible to recruit and retain participants to a trial of surgerycompared with active monitoring for X(T).
Despite screening, the anticipated number of children with X(T), recruitment levels fell short of those
predicted. This can be attributed to two issues.
First, the proportion of children eligible for inclusion was much lower than anticipated. This was primarily
due to the proportion of screened children who did not have a severe enough strabismus for inclusion.
Tightening the inclusion criteria to conform with current clinical practice would, while reducing the number
of potential recruits overall, increase the proportion eligible.
This has been discussed with the centres involved in the pilot and other potential interested centres.
Children who were eligible but randomised had poorer control of their X(T) than those who were eligible
but declined to participate. This does give rise to an important issue about generalisability of a trial of
surgery, which we will consider in any future trial. It is clear that we will be able to randomise children to a
trial involving surgery only if their parents are prepared to consider surgery as a treatment, implying that
the results will be applicable only to this group of patients. Should a trial show that surgery gives more
favourable outcomes, this might lead to more parents considering surgery as an option.
Second, given the expressed views of many parents (of children who are eligible for inclusion) regarding
their preferences, both for and against, surgical treatment for X(T), the development of a formal RCT
should include consideration of a preference arm, which would increase the participation of
eligible children.
An alternative strategy that could be considered, particularly if a future trial were to be designed around
the benefit of early surgery, would be to randomise children aged < 4 years to surgery or active
monitoring, bearing in mind that only parents who would consider early surgery as a treatment would be
prepared to be randomised. This would leave open the possibility of later surgery in the active monitoring
arm should the condition deteriorate or parents request surgery.
There was little evidence of significant deterioration of X(T) in children in the active monitoring arm,
strengthening the case for a formal RCT.
The process of screening and recruitment evolved during the pilot, with an increase in the proportion of
eligible children recruited. A more realistic assessment of the time required in clinic, and more astute use
of research nurses, would be required for a further study.
The lack of a generic QoL measure that demonstrates the effect of X(T), and the emphasis on parental
anxiety in the available disease-specific instrument are of concern. A longer-duration trial would allow the
possibility of more children being able to express their own views at outcome, which would enable a more
robust estimate of the effect of the condition on QoL.
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Chapter 8 Suggestions for further research
Hypothesis generation
The SamExo study was a stand-alone pilot study to assess the feasibility of a full trial of surgery compared
with active monitoring for X(T). Although not powered to assess the effectiveness of surgery as an
intervention, the clinical outcomes do indicate agreement with previous research, which suggests that,
over a short follow-up period, the majority of patients who are actively monitored do not significantly
improve or deteriorate, whereas most patients who undergo surgery have, in the short term, improved
alignment, albeit with a rate of between 10% and 20% of overcorrection with a deterioration in
stereoacuity. The proportion of patients who are ‘cured’, i.e. demonstrate no significant strabismus while
having preserved stereoacuity is low, at 36%.
There are two questions that then arise:
1. What are the long-term outcomes of surgery and active monitoring? Most studies indicate that there
is a significant rate of recurrence of strabismus in children who have undergone surgery for X(T).50,77,78
As discussed in the systematic review, one study50 showed that recurrences were most common within
6 months from surgery; however, after that, recurrences occurred continuously in the R&R group
and rarely in the BLR group. In a further study, the Kaplan–Meier rate of developing ≥ 10 (delta) of
misalignment after the first surgery was 54% by 5 years, 76% by 10 years and 86% by 15 years.78 This
indicates that outcomes from surgery may not be stable, which needs to be taken into account in the
design of a future trial.
The data on spontaneous cure rates in children who have not undergone surgery are less clear. The lack of
randomised studies means that children who have not undergone surgery will tend to have a less severe
strabismus than those who have. Nevertheless, there are studies that suggest that a proportion of children
with X(T) will show spontaneous improvement36 or at least no deterioration.79
This suggests the possibility that the long-term outcomes following strabismus surgery for X(T) may be no
better than a strategy of awaiting spontaneous improvement.
We would propose that a future trial would follow up children for at least 5 years from recruitment.
Although this might seem onerous, an annual assessment of outcomes might be sufficient, reducing the
burden on participants.
Furthermore, a longer-term study would be better able to assess QoL outcomes from a participant
perspective, as most of the participants in the pilot study were too young to give their view.
This suggests the need for a formal RCT of surgery compared with active monitoring, which incorporates
long-term follow-up of participants in the trial.
2. How can the cure rate of surgery be improved? There are sound theoretical reasons for the view that
outcomes from strabismus surgery in children are improved if the surgery is undertaken soon after the
onset of strabismus.80–82 There is evidence of improved outcomes from early surgery in infantile esotropia
(convergent strabismus).83,84 The evidence supporting early surgical intervention in X(T) is less clear.
A widely cited study by Pratt-Johnson et al.85 showed evidence of improved outcomes from surgery
for X(T) undertaken in children aged < 4 years.
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We have shown in a previous study20 that rates of surgery for X(T) within 2 years of presentation are low in
the UK, indicating a reluctance among clinicians in the NHS to adopt a practice of early surgery. Qualitative
interviews undertaken by our group (Lecouturier et al., submitted to BMC Ophthalmology) indicated that
the reasons behind this reluctance included:
l difficulty in assessment of young children, particularly those under 4 years, in whom measurements of
stereoacuity and strabismus angle are inaccurate
l the need for repeat assessment owing to variability of X(T) in order to plan the need for and the
amount of surgery
l concerns about the more severe functional impact of overcorrection of X(T) in younger children,
particularly the development of amblyopia in cases where a constant esotropia develops.
Although these concerns are valid, given the low short-term cure rates following surgery undertaken at
an older age, and the high rates of recurrence following surgery, there is clearly a need to consider
whether or not an alternative treatment strategy would be more effective than deferring surgery until the
child is old enough to obtain accurate measurements, by which time the X(T) has usually been present for
several years. This suggests the need for a formal RCT that incorporates early surgery as an intervention.
What lessons from the pilot randomised controlled trial should be
incorporated into a full randomised controlled trial?
A full RCT of surgical treatment of X(T), testing either the effect of surgery at any age or early surgery
against active monitoring, would face a number of challenges, some of which have been highlighted
in this pilot study. The principal issue is likely to be the recruitment of sufficient participants. The pilot
has clarified that parents are very unlikely to accept the possibility of randomisation to surgery at the
presenting visit to an eye clinic. This implies that prevalent cases would have to be included as potential
participants. This potentially induces a bias, which would be partially overcome in a trial of early surgery
with a limit on the upper age at which participants would be included.
A further issue was the difficulty of the potential conflict between clinical function of the ophthalmologist
and recruitment, and we would recommend that research nurses are used for recruitment in all centres in
a future trial.
Recruitment to a full trial is also likely to be hampered by strong parental preferences, as demonstrated in
this pilot. Although, given enough centres, sufficient participants could be recruited to deliver a full trial,
there would be issues about generalisability. There are two possible solutions to this issue: either to
incorporate a preference arm or to accept that recruitment will inevitably be restricted to those parents
who are prepared to consider surgery as a treatment, with the restrictions on generalisability entailed.
The pilot has also indicated intercentre differences in recruitment and outcome, and in a study with more
centres it would be important to further standardise surgery and other treatment, including management
of postoperative overcorrections and undercorrections.
We would argue that the IXTQ should be used in a full trial, as a condition-specific QoL measure, but,
in addition, a generic measure will be required. A longer-duration study would allow the collection of
child-reported QoL information, which has not been possible with many younger patients in this pilot.
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What are the risks of not commissioning further research in this area?
The current clinical management of strabismus owes more to art than to science, and is heavily driven by
parental preferences, which may, or may not, be clinically appropriate. There is an urgent need to obtain
more robust evidence to guide practice for this large group of patients, which has been highlighted by
a recent study highlighting variations in clinical practice within the NHS in this area.10
A recent workshop hosted by the James Lind Alliance for patients and eye health professionals identified
the improvement of treatments for exotropia as a priority.86
A formal RCT of the treatment of X(T) incorporating an active monitoring arm is required to begin to
resolve the current uncertainties in the management of this condition.
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Appendix 1 Example search strategy
MEDLINE (via Ovid)
1. Exotropia/
2. (divergen$ adj10 (excess$ or strabismus or squint$)).tw.
3. (exotrop$ or IDEX).tw.
4. or/1-3
5. limit 4 to humans
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Appendix 2 Data extraction form
Reviewer Study ID Source
Country study
conducted Language
Full citation
Corresponding study
author and contact
details
Eligibility (yes or no)
Does the study consider exotropia rather than some other
form of misalignment?
Does the study address X(T) (rather than
permanent exotropia)?
Does the study involve children aged ≤ 16 years?
Does the study design include a comparator group?
Is the sample size > 20 participants?
Methods and participants
Study design
Setting
Intervention(s)
Duration of intervention
Contextual factors
Population (age)
Population [severity of X(T)]
Population (time since diagnosis)
Method of recruitment and control group selection
(if appropriate)
Total population
Baseline response (no. and rate)
Time between baseline and follow-up
Follow-up response
Final sample size
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Results and outcomes
Primary outcomes assessed
Tools used to assess primary outcomes
Secondary outcomes assessed (include QoL and
patient-derived outcomes)
Tools used to assess secondary outcomes
Intervention group: effect sizes with CIs and p-values
(or relevant statistics)
Control group: effect sizes with CIs and p-values
(or relevant statistics)
Incidence of adverse effects (for inception cohort studies)
Data about natural history of X(T)
Notes/comments (include possible conflict of interest)
Correspondence required (additional study data)
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Appendix 3 Quality appraisal tools
Cochrane risk of bias tool for randomised controlled trials
(http://bmg.cochrane.org/research-projectscochrane-risk-bias-tool)
Domain Support for judgement
Selection bias
Random sequence generation Describe the method used to generate the allocation sequence
in sufficient detail to allow an assessment of whether or not it
should produce comparable groups
Allocation concealment Describe the method used to conceal the allocation sequence
in sufficient detail to determine whether or not intervention
allocations could have been foreseen in advance of, or
during, enrolment
Performance bias
Blinding of participants and personnel: assessments
should be made for each main outcome (or class
of outcomes)
Describe all measures used, if any, to blind study participants
and personnel from knowledge of which intervention a
participant received; provide any information relating to
whether or not the intended blinding was effective
Detection bias
Blinding of outcome assessment: assessments
should be made for each main outcome (or class
of outcomes)
Describe all measures used, if any, to blind outcome assessors
from knowledge of which intervention a participant received;
provide any information relating to whether or not the
intended blinding was effective
Attrition bias
Incomplete outcome data: assessments should be
made for each main outcome (or class of outcomes)
Describe the completeness of outcome data for each main
outcome, including attrition and exclusions from the analysis;
state whether or not attrition and exclusions were reported,
the numbers in each intervention group (compared with total
randomised participants), reasons for attrition/exclusions where
reported, and any re-inclusions in analyses performed by the
review authors
Reporting bias
Selective reporting State how the possibility of selective outcome reporting was
examined by the review authors, and what was found
Other bias
Other sources of bias State any important concerns about bias not addressed in the
other domains in the tool[***]If particular questions/entries
were prespecified in the review protocol, responses should be
provided for each question/entry
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Quality Appraisal Tool for Cohort Studies (adapted from
Critical Appraisal Skills Programme)
1. Was the cohort recruited in an acceptable way?
2. Was the study prospective?
3. Was the intervention conducted in an explicit and standardised manner?
4. Was the outcome appropriately measured to minimise bias?
5a. Did they identify all potential important confounding factors?
5b. Did they adjust for confounding factors in the design and/or analysis?
6a. Were they followed up for at least 12 months?
6b. Were at least 80% of participants followed up (for prospective studies)?
7. Are the authors’ conclusions substantiated by the reported data?
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Appendix 4 Table of excluded studies after
full-text review
Study (first author, year) Reason for exclusion
Abbas 197587 No separate data for intermittent vs. constant (says in methods section that there are
both); no separate data for children (patients aged 2.5–27 years)
Abbasoglu 199688 No data for X(T), grouped as exotropia only
Abroms 200189 No separate data for children, adults and children mixed (upper age of sample
18.4± 16.0 years)
Adams 200890 Fewer than 20 cases and data for children and adults mixed
Akar 201291 Not all X(T) in case series and only 25 cases of exotropia in total
Akatsuka 200192 No separate data for X(T)
Alajbegovic´-Halimic´ 200793 No data reported separately for X(T), exotropia only
Altizer 197294 Sample size, 13 conservative intervention+ 16 surgical X(T) remainder XT;
interventions – occlusion, convergence exercises, prisms
Ameri 201095 Children and adults mixed, also no subgroups so unable to extract X(T) data from other
types of squint
Archer 200996 No disaggregated data are available for X(T)
Arnoldi 200897 Not an intervention study
Asadi 200998 Mixed population of adults and children and follow-up only 13.5 weeks
Asjes-Tydeman 200699 Effectiveness data not available separately for X(T)
Aslanis 2006100 No comparison group
Attarzadeh 2008101 No comparison group, case series data only
Awadein 2012102 Sample size fewer than 20 patients (only 7 of 25 with A-pattern strabismus including
exotropia and esotropia)
Awadein 2008103 Sample size fewer than 20 patients with X(T)
Awaya 1982104 Sample size fewer than 20 patients with XT [only six patients with X(T)]
Bae 2012105 Outcomes not assessing intervention effectiveness
Baker 2008106 No comparison group, case series data only
Baker 1979107 No comparison group, case series data only
Bansal 2008108 Considers adults, no separate data for children
Bao 2006109 No comparison group, case series data only
Barraza 2009110 Does not consider effectiveness of surgery
Basar 2000111 No comparison group, case series data only
Beneish 1994112 No comparison group, case series data only
Berard 1979113 No comparison group, case series data only
Berard 1979114 No intervention comparison group, looks at overcorrected subset only
Berard 1975115 No comparison group, case series data only; largely a discursive piece on classification
and diagnosis
Berg 1983116 Data not presented separately for basic, convergence insufficiency and distance excess
Berland 1998117 Sample size fewer than 20 cases of X(T)
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Study (first author, year) Reason for exclusion
Berrondo 1980118 Does not include empirical data on effectiveness
Besharati 2008119 No data for X(T)
Bietti 1970120 Fewer than 20 cases and no mention of X(T) specifically
Billet 1969121 No comparison group, case series data only (case reports, n= 11)
Binion 1966122 No comparison group, case series data only
Bramante 200956 Conference abstract only and no response from study authors
Brandner 2011123 No outcomes of interest (not an intervention study)
Brooks 2011124 Fewer than 20 patients with exotropia and no mention of X(T)
Broniarczyk-Loba 2003125 Mostly adults, no separation of results for children (n= only 25 in total)
Broniarczyk-Loba 1994126 ET and XT mixed, no data for X(T) separately
Buck 201225 No comparison group, case series data only
Caldeira 2004127 Fewer than 20 cases, [looking into cases in detail, only 13 X(T)]
Caltrider 1983128 No comparison group (case series data only)
Capo 1989129 Constant and intermittent mixed, no separate data for X(T) and n= 24 only in total
Carlton 2011130 No intervention or natural history data (explores prevalence of eye disorders, risk factors
and relationships with QoL)
Carta 1994131 Adults and children in sample, age range 0–32 years, no separate data for children
Cassin 1986132 Sample size fewer than 20 patients
Castelbuono 1999133 Not addressing outcomes of interest
Castellanos-Bracamontes
1990134
Descriptive study, not an intervention study
Celebi 2001135 Adults and children mixed, range 4–51 years, no separate data for children
Chae 2008136 Recurrent X(T)
Chang 2008137 Does not address question of interest
Chang 2006138 Data for adults and exotropia generically only (n= 48), no separate data for X(T)
Chia 200649 No comparison group, case series data only
Chia 2005139 Some patients with convergence insufficiency type and outcomes not reported separately
Cho 2012140 No comparison group, case series data only
Cho 2009141 Follow-up only 3 months
Cho 2007142 No comparison group; mean age 11.4± 7.2 years; includes subjects > 18 years
(5–19 years)
Choi 2011143 No comparison group, case series data only
Choi 2001144 Convergence insufficiency subtype
Chryssanthou 1974145 Adults and children mixed population age range 5–33 years; data for children not
reported separately
Chun 2010146 No outcomes of interest
Chun 2008147 Recurrent exotropia
Chung 2012148 No comparison group, case series data only
Chung 2011149 Adults and children mixed, data not reported separately for children
Chutter 1977150 Cannot separate out data for adults and convergence insufficiency type
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Study (first author, year) Reason for exclusion
Ciancia 1969151 Fewer than 20 patients (n= 15)
Clark 2009152 Not X(T) and fewer than 20 patients (n= 8)
Clarke 1981153 No comparison group, case series data only
Cooper 1983154 Convergence insufficiency type and only seven patients
Cooper 1977155 Cannot separate out patients with convergence insufficiency type who represent 11.1% of
the sample
Dadeya 2003156 No comparison group, case series data only
Dahlmann 2007157 Groups differ on basis of condition rather than intervention vs. comparison
Dawson 1999158 No intervention comparison group
Debert 2007159 No data reported for X(T), only exotropia in general
DeDecker 1988160 Adults and children mixed and fewer than 20 patients with X(T)
Deitz 2011161 No comparison group, case series data only
DeLianoSanchez 1997162 Results not reported separately for X(T)
Demers 1971163 Includes convergence insufficiency type
Deng 2009164 Fewer than 6 months’ follow-up
Deutsch 1992165 Exotropia generally (n= 30) not X(T) subtype
Dong 2006166 Exotropia generally not X(T) subtype
Donnelly 2005167 Prevalence study with only sparse outcome data for interventions, where n= 10 for
exotropia and only five for intermittent divergence excess type
Dzelkaleia 1985168 Not an intervention study
Edelman 1988169 No comparison group
Ekdawi 2010170 Follow-up < 6 months
Ekdawi 200978 Data for adults and children mixed (age at time of intervention > 18 years), no separate
data for children
El-Defrawi 1970171 Not possible to identify X(T) outcome separately
Engel 2004172 No separate data for X(T) and no data on initial deviation
Eustace 1972173 Fewer than 20 cases with divergent squint
Faridi 2007174 Adults and children mixed and no data for children presented separately
Fastrez-Moutschen 1993175 Not X(T), exophoric cases only, also case series (no adequate comparison group)
Feretis 1999176 No comparison group, case series data only
Fiorelli 2007177 Data for adults and children mixed, age range 5–55 years and data not reported separately
for children
Friedman 1980178 Prevalence study, no intervention
Friemel 1971179 No patient outcomes
Gagnon 1970180 Adults and children mixed, and no comparison group
Gezer 2004181 Outcome data are for intermittent and constant mixed
Gharibyan 2012182 Subjects with vertical component (n= 20 only)
Goldrich 1980183 Data for adults and children mixed, no separate data for children (n= 28); also unclear
how many are X(T)
Goldstein 1968184 Sample size fewer than 20 patients and not all X(T)
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Study (first author, year) Reason for exclusion
Gordon 1980185 Age range is up to 20 years; also not examining intervention effectiveness, reports on
predictor models for surgery
Govekar 1993186 No data for X(T) specifically
Govindan 200514 Epidemiological study, looking at incidence only; no intervention or follow-up
Graemiger 1979187 No patient outcome data on effectiveness
Graf 2002188 Comment on an important paper (keep for discussion)
Guo 2011189 Case series, no comparison group
Guo 2009190 Case series, no comparison group
Gupta 1987191 No intervention, considers association of various refractive errors in cases of exophoria
Gusek-Schneider 2006192 Children and adults mixed, children and adults (age range 3.1–47.8 years); also minimum
range of follow-up period is only 6 weeks
Ha 2011193 Adults in sample and some patients with constant or recurrent XT
Haggerty 200471 No outcome data on intervention effectiveness
Hahm 2005194 Cases of recurrent exodeviation therefore not outcomes from the primary intervention
Hamaguchi 1993195 No comparison group, case series data only
Hamtil 1978196 Sample size fewer than 20 X(T) (mostly constant)
Hao 2009197 No comparison group, case series data only
Hardesty 1983198 No comparison group, case series data only (considers those undercorrected or with
a recurrence)
Hardesty 1978199 No comparison group, case series data only
Hatsukawa 2011200 Case series data only, no comparison group
Hatsukawa 1992201 No comparison group, case series data only
Hatt 2012202 No effectiveness data (conference abstract only)
Hatt 2010203 No effectiveness data considers classification only (conference abstract)
Hatt 2007204 Not considering intervention effectiveness (before-and-after data for seven patients only)
Herzau 1993205 Not considering intervention effectiveness
Hiles 1968206 No comparison group, case series data only
Holmes 2010207 No comparison group, case series data only
Holtgrave 1973208 Not intervention effectiveness
Hu 2012209 Adults and children mixed sample, no separate data for children
Huang 2010210 No separate outcome data for X(T) and data for adults and children mixed
Hugonnier 1970211 No comparison group, case series data only
Hugonnier 1967212 No comparison group, case series data only
Hunter 2001213 Fewer than 20 cases [n= 7 X(T)]
Iacobucci 1986214 No comparison group, case series data only
Inagaki 1993215 No comparison group, case series data only and no outcome data to address question
of interest
Ing 2011216 No comparison group, case series data only
Ing 1999217 No comparison group, case series data only
Ing 1986218 Constant and intermittent exotropes combined, no separate data for X(T)
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Study (first author, year) Reason for exclusion
Isenberg 2009219 No data for X(T) separately and adults/children mixed population
Israel 201157 Conference abstract only and no response from study authors
Jacobi 1969220 Fewer than 20 cases
Jang 2012221 No comparison group, case series data only
Jeoung 2006222 RCT but outcome data not available for intermittent and constant exotropes separately
Jojic 1987223 Not X(T)
Jung 2012224 Not considering intervention effectiveness, no outcomes of interest and follow-up
3 months only
Kamai 200858 Conference abstract, have written to study authors but no response
Kang 2011225 Only 6-week follow-up
Kampanartsanyakorn
2005226
No data for X(T) specifically, refers to exotropia generically only
Kaszli 1997227 Reporting on outcomes of surgery for exotropia and esotropia generically with no data
on subtypes
Keenan 1994228 No comparison group, case series data only
Kertesz 1986229 Data for adults and children mixed (age range 4.5–70 years), no outcomes for
children separately
Keskinbora 2012230 Data for adults and children mixed (range 6–25 years), data for children not
reported separately
Khaier 2008231 Not X(T)
Kii 1992232 No outcomes of interest
Kim 201059 Conference abstract only and no response from study authors
Kim 2005233 Outcome data not reported separately for adults and children and data for X(T) not
reported separately from XT
Kliuka 1987234 Not an intervention study
Koklanis 2010235 No comparison group, case series data only, all types of X(T) included,
no effectiveness data
Koo 2006236 No comparison group, case series data only
Kosaki 1967237 Not X(T), constant, also no comparison group, case series data only
Kubota 1977238 No outcomes of interest, focuses on classification
Kushner 2009239 Re-analysis of data from earlier studies
Kushner 1999240 Fewer than 20 cases (n= 16, subset of 304 consecutive case series)
Kushner 1999241 No outcomes of interest (i.e. no postintervention data for angle of deviation) – rather looks
at whether or not myopia is a consequence of overminus lens therapy
Kushner 1998242 Does not consider question of interest
Kushner 1993243 Cannot separate data for X(T) and constant
Kushner 1989244 Fewer than 20 patients [only 17 with X(T)]
Kushner 1988245 No comparison group, case series data only
Kutschke 1988246 Fewer than 20 patients
Lahlou 1971247 Fewer than 20 patients (three cases)
Lak 1997248 Deviation is at near for most patients (n= 28) only seven basic type
Lange 2009249 Literature review
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Study (first author, year) Reason for exclusion
Lange 1993250 Also adults and children mixed, outcome data not available separately for adults and
children; cannot separate out divergence excess from convergence insufficiency type
Lee 2012251 No comparison group, case series data only
Lee 2012252 No comparison group, case series data only
Lee 2011253 Fewer than 20 patients who had not previously had surgery (n= 17)
Lee 2009254 Not considering intervention effectiveness, no outcomes of interest
Lee 1997255 Sample aged up to 21 years at time of intervention and cannot separate data for children;
also minimum range of follow-up period is 2 months and mean is 5.3 months
Lennerstrand 1986256 Cannot separate data for X(T) from constant exotropia
Leonardi 1993257 Adults and children mixed, does not present effectiveness data by age
Leonardi 1970258 No effectiveness data (selective group)
Leow 201075 No comparison group, case series data only
Lew 2007259 Not considering outcomes of interest
Lim 2012260 No relevant comparison group for the intervention
Lim 2011261 No comparison group, case series data only; also data for adults and children not separate
(age range at time of intervention 3–43 years)
Litwinska 1997262 Data for exotropia and esotropia not available separately
Livir-Rallatos 2002263 Adults and children mixed, cannot separate outcome data for children, also includes
constant as well as symptomatic X(T)
Liu 2010264 No separate outcome data for X(T)
Liu 2005265 Sample size, fewer than 20 cases
Lucas 1994266 Sample size, fewer than 20 cases
Marrakchi 1994267 No comparison group, case series only
Martin 1989268 No comparison group, case series only
Maruo 1988269 No comparison group, case series only
Matsusaka 1988270 No comparison group, case series only
McNeer 1987271 No comparison group, case series only
McSwain 2011272 No comparison group, case series only
Melek 1992273 Not an intervention study
Menon 2010274 Follow-up only 3 months
Metz 1988275 Does not identify X(T) separately; considers cases with vertical squint
Miller 1994276 Considers only cases of consecutive esotropia after surgery
Mims 2011277 Not an intervention study
Mims 2008278 Not an intervention study
Mims 2008279 No outcomes of interest
Mims 2003280 Not the primary intervention
Minguini 2005281 No data for X(T) separately
Mitsui 1980282 No data for X(T) separately
Mojon 2010283 Not examining intervention effectiveness, adults and children in sample and fewer than
20 patients with follow-up
Moore 1977284 No intervention data, largely a descriptive piece
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Morrison 2010285 No comparison group, case series data only, only 2-month follow-up
Morrison 2009286 No comparison group, case series data only, only 2-month follow-up
Mumma 1975287 Data mixed for adults and children, cannot separate data for children and X(T) from
constant exotropia
Nelson 1992288 No comparison group, case series data only; also data for adults and children mixed,
cannot separate data for children
Nowakowska 2009289 No comparison group, case series data only
Nusz 2006290 Follow-up period of < 6 months for some patients
Oh 2006291 Data for intermittent and constant exotropia mixed, also includes some convergence
insufficiency types
Ohtaki 2000292 Sample size, fewer than 20 patients with X(T)
Ohtsuki 2001293 Cannot separate data for children, mean age 17.8 years, range 4–56 years and sample
includes some convergence insufficiency types (n= 39)
Ohtsuki 1997294 Data for adults and children mixed, cannot separate data for children
Oleszczynska-Prost 2004295 Sample size fewer than 20 cases
Olitsky 1998296 No comparison group, case series only
Orlin 2007297 Data for exotropia in general, no data for X(T) specifically
Owen 2010298 Not assessing intervention effectiveness, considers incidence of adverse effects only
Paakkala 1982299 No comparison group, case series only
Pajakowa 1973300 No comparison group, case series only
Paris 1998301 Sample size fewer than 20 patients
Park 2008302 No data for X(T) specifically, XT only
Parkesh 1984303 Not X(T)
Patel 1988304 Sample size fewer than 20 patients
Paula 2009305 No outcomes of interest
Pietruschka 1973306 No data for X(T) separately
Pineles 201126 Only considers patients with consecutive esotropia
Pineles 201076 No relevant comparison group, also, adults in sample and includes convergence
insufficiency type
Pineles 2009307 No relevant comparison for the interventions (groups differ on the basis of condition rather
than on basis of intervention); also data for adults and children mixed
Pratt-Johnson 1979308 Follow-up only 1 month
Pratt-Johnson 197784 No comparison group, case series only
Qiu 2012309 Not examining intervention effectiveness in the long term, considers stereo vision pre and
only 1 week postoperatively
Rajavi 2001310 Does not report on X(T) specifically (esotropia and exotropia in general)
Remy 1990311 Sample size, fewer than 20 cases
Richard 1983312 No comparison group, case series only
Rodrigues 2005313 Exotropia in general, no specific data for X(T)
Rodrigues 2006314 Exotropia in general, no specific data for X(T)
Rohatgi 1982315 No comparison group, case series data only
Romanchuk 200636 No comparison group, case series data only
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Ron 1985316 No separate data for X(T)
Roth 1981317 No comparison group, case series only
Rowe 200944 No separate data for X(T), as data for adults and children mixed (range 1–79 years)
Rowe 1990318 Sample size fewer than 20 patients
Rutstein 2003319 No separate data for children, also outcomes for convergence insufficiency mixed with
basic and divergence excess types
Rutstein 1989320 No outcomes of interest and no comparison group (case series data only)
Ruttum 199773 No comparison group, case series data only, also data for adults and children mixed
Santos 2011321 Sample size fewer than 20 patients with exotropia and no mention of X(T)
Saxena 2011322 Adults in sample, no separate data for children only
Schulz 1984323 No comparison group, case series only
Schwartz 1980324 No data for X(T) separately and adults and children mixed population
Scott 1990325 Does not separate X(T) from exotropia in general
Scott 1975326 Sample age fewer than 20 patients
Segal 2000327 Not data for X(T) specifically
Self 2004328 No data for X(T) specifically
Sethi 2008329 No data on intervention effectiveness
Shippman 1979330 Follow-up < 6 months
Siatkowski 2010331 Not an intervention study
Singh 1992332 Children and adults mixed, no separate data for children, also some cases of convergence
insufficiency cases included
Smoot 1990333 Sample size fewer than 20 patients, subgroup of overcorrected ET and n= 9
Somer 2007334 Convergence insufficiency type
Spencer 199722 No comparison group data reported
Spielmann 1983335 Adults and children mixed and no mention of X(T) specifically
Spierer 2010336 No data for X(T) separately
Spierer 2005337 No data for X(T) separately, also adults and children mixed population
Spoor 1979338 Not X(T)
Stoller 1994339 No separate data for X(T) and adults and children mixed
Strogal 1983340 No comparison group, case series only
Stuteville 2007341 No intervention and adults
Suh 2006342 Follow-up < 6 months
Sun 2010343 No data reported for X(T) separately
Tae 2005344 No comparison group data on effectiveness, also adults and children mixed
Tao 2008345 No data for X(T) separately, adults and children mixed
Tatham 2009346 Data for adults and children mixed, also no data for X(T) separately
Thouvenin 2008347 Not X(T)
Tibbs 1978348 Sample size fewer than 20 patients with X(T)
Tsuji 1988349 No separate data for X(T)
Usui 2000350 No comparison group, case series only
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Vishnoi 1987351 Adults and children mixed, no separate data for children
Wang 2010352 No comparison group, case series only
Wang 2009353 No comparison group, case series data only
Wang 2008354 No comparison group, case series only
Weakley 1993355 No separate data for X(T) and adults and children mixed
Weston 1991356 Outcomes for XT generally (n= 34), no data for X(T) specifically
Wickens 1984357 No comparison group, case series only
Wilson 1989358 No effectiveness data for X(T)
Windsor 1971359 Follow-up < 6 months
Wu 2007360 No comparison group, case series only
Wu 2006361 No comparison group, case series only
Wutthiphan 2008362 Data for adults and children mixed
Wygnanski-Jaffe 1999363 No data for X(T) specifically only XT and ET generally
Xu 2012364 Not intervention effectiveness, focuses on adults
Yam 2012365 No comparison group, case series only
Yan 2006366 No mention of X(T) specifically
Yang 2008367 No comparison group, case series only
Yang 1984368 Follow-up only 6 weeks
Yao 1993369 No comparison group, case series data only
Yazdian 2006370 Sample size fewer than 20 patients
Yi 2011371 No data for X(T) separately, pools exotropia and esotropia and includes consecutive as well
as primary cases
Yildirim 1999372 Adults and children mixed sample, no data for children separately
Yin 2002373 Data for adults and children mixed
Yu 1989374 No comparison group, case series data only
Zaki 1972375 No intervention, descriptive epidemiological data on prevalence of types of XT
Zhi 2008376 No specific data on X(T) discusses XT only
Zibrandtsen 1986377 Sample size fewer than 20 patients with basic or divergence excess type X(T)
Ziegler 1982378 Review, no empirical data
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Appendix 5 Intermittent Exotropia Questionnaire
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Appendix 6 Survey of UK ophthalmology units
An e-mail survey was conducted using the paediatric ophthalmology e-mail Listserv PAED-OPHTH-STRABISMUS list (157 recipients, including trainees).
There were 38 respondents, 37 of whom operated on X(T). Of these 37 respondents, 35 (95%) indicated
that they would be willing to participate in a future RCT, although one is now practising outside the UK.
Reasons for being unwilling
1. ‘Probably unethical.’ (This was the one who did not operate but still answered this question.)
2. ‘Probably not rather than absolutely not, 2 reasons: 1. parents probably won’t accept it. 2. I would be
concerned about loss of BSV.’
3. ‘The decision for surgery is one made by the parents and the surgeon. Hence to randomise to no
treatment after this decision I feel will be a major stumbling block.’
Potential barriers
Potential barriers to such a trial succeeding broadly fell into three main themes: loss to follow-up
(mentioned by four people), dropout rates (four people) and the unwillingness of parents to wait for
surgery (eight people). Other issues included definitions of squint severity and outcomes:
1. Loss to follow-up:
i. ‘Long follow-up would increase the DNA rate especially in the surgical cases that were successful.’
ii. ‘Losing people under follow-up.’
iii. ‘Loss of patients to follow up.’
iv. ‘Failure to continue follow-ups.’
2. Dropout rates:
i. ‘Parents motivation to continue lengthy follow-up period. There will be more dropouts in the
observation group in favour of surgery.’
ii. ‘Parents may decide to go to another centre for surgical treatment.’
iii. ‘Change of mind by parents.’
iv. ‘Dropout because of child being teased at school.’
3. The desire for surgery/unwillingness to wait:
i. ‘Many parents are keen for surgical intervention and it may be difficult to monitor them for 5 years.’
ii. ‘In case of severe intermittent XT, may be difficult to convince parents for observation alone.’
iii. ‘Parents desire for surgery.’
iv. ‘Pressure from parents wanting surgery.’
v. ‘Patient/parental pressure for surgery with worsening control.’
vi. ‘Difficulty convincing parents that it is satisfactory to monitor especially if their child/teacher
complains of difficulty seeing the smart board.’
vii. ‘Once you mention surgery – parents commonly don’t want to wait.’
viii. ‘Parents may not want to be randomly assigned into one group especially those not
wanting surgery.’
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4. Criteria/definitions:
i. ‘Defining the outcome and what constitutes success/failure.’
ii. ‘Investigators agreeing the definition of “moderate to severe” as the point at which surgery is
recommended is so variable across the UK currently.’
iii. ‘I think the real difficulty would be in trying to rationalise not only the type of surgery, but also the
aim of the surgery. Do you leave them XT or aim to prevent outdrift by making them ET and
risk amblyopia?’
5. Random:
i. ‘Culture amongst some orthoptic colleagues of advising parents that child should have operation
based on angle or stereo or age. (“I’ll send you through to the consultant so they can add you to
the waiting list,” etc.). This may affect parental attitudes to being randomised.’
ii. ‘Ethics management pressures on workload.’
iii. ‘Will need to be clear when patients can withdraw if binocularity threatened.’
Question: How important do you think it is to conduct
a randomised controlled trial of the clinical effectiveness
of surgery versus active monitoring in this condition?
Seventeen (46%) felt that it was very important, 17 (46%) quite important and 3 (8%) not very important.
(One skipped.)
Question: How important do you think it is to conduct a
randomised controlled trial of the cost effectiveness of surgery
versus active monitoring in this condition?
Eight (22%) felt it was very important, 20 (54%) quite important and 9 (24%) not very important.
(One skipped.)
Other comments
Interesting idea but personally I would prefer to await outcome of such a trial before delaying
surgery in children for whom I currently offer surgery.
5 years seems like a long period to monitor. During period or monitoring would you suggest over
minus glasses or convergence exercises. What criteria would move a child from monitoring
to surgery?
5 years is ambitious – but probably necessary – and I guess with necessary checks (i.e. break code
if obviously doing worse)
I think the first trial should be on observation versus surgery in moderate control, as this is more
ethical and management for this varies between departments you may even compare with
minus lenses.
Are there any plans to include a third arm for BTxA?
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Having trained in the UK and now practising in my home university hospital (Thessaloniki, Greece),
I wonder if you’d be interested in non-UK participants in your current and future studies. If so,
what would be minimum requirements?
This respondent was based in Wales and indicated he would not be willing:
Mike- this is what I feel though I feel for the establishing a natural history it is extremely important
but will be difficult to recruit in my practice – but I’m willing to give it a go.
Good luck Mike.
Go for it guys. Answers not found yet!
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Appendix 7 Participant Costs Questionnaires
Health Service Use Questionnaire (Part A)
1a. Has your child seen or contacted a GP because of his or her eyes during the last 3 months?
YES
NO
1b. If YES to Question 1a, how many appointments did your child attend with a GP?
1c. If YES to Question 1a, how many times did a GP visit your child at home?
1d. If YES to Question 1a, how many times did you or your child have a telephone conversation with
a GP?
2a. Has your child see a practice nurse because of his or her eyes during the last 3 months?
YES
NO
2b. If YES to Question 2a, how many times in total?
3a. Has your child seen a community optician or optometrist during the last 3 months?
YES
NO
3b. If YES to Question 3a, how many times in total?
4a. Has your child seen a hospital specialist (consultant or one of his/her team) because of his or her eyes
other than attending planned follow-up visits during the last 3 months?
YES
NO
4b. If YES to Question 4a, how many times in total?
5a. Has your child been admitted to hospital because of his or her eyes during the last 3 months?
YES
NO
5b. If YES to Question 5a, how many nights was your child in hospital (if admitted as a day case, please
enter 0)?
6a. Has your child had prescription medicine for his or her eyes during the last 3 months?
YES
NO
6b. If YES to Question 6a, what type of medication has your child been prescribed?
Name of the medicine No. of times prescribed
Antibiotic
Steroid
Painkillers
Other
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7a. Have you purchased over the counter medicine (e.g. eye drops) for your child’s eyes during the last
3 months?
YES
NO
7b. If YES to Question 7a, how much did you pay in total?
8a. Have you paid for any other private health care for your child because of his or her eyes during the last
3 months?
YES
NO
8b. If YES to Question 8a, what type of care did you pay for?
8c. If YES to Question 8a, how much in total did it cost?
9a. Have you taken time off from work to look after your child because of his or her eye condition other
than attending planned follow up visits during the last 3 months?
YES
NO
9b. If YES to Question 9a, how many days in total were you absent from work?
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Time and Travel Questionnaire (Part B)
Please note that this questionnaire assumes that for every form of health care your child attended, you
have travelled with and accompanied your child. If your child travelled alone, please only include the costs
that incurred to your child.
Part 1 – Your child’s most recent admission to hospital because of his or
her eyes
If in the last 3 months your child was not admitted to hospital please go to Part 2.
1. Please circle the number that best describes how you and your child travelled. If more than one form of
transport was used, please indicate the way you travelled for the main (longest in terms of distance)
part of your journey.
Bus_____________________________________________________________________________________1
Train___________________________________________________________________________________2
Taxi____________________________________________________________________________________3
Private car_______________________________________________________________________________4
Hospital car_____________________________________________________________________________5
Ambulance______________________________________________________________________________6
Other (please specify)_____________________________________________________________________7
2. If you and your child travelled by bus, train or taxi to hospital what was the total cost of the (one-way)
journey? Please write the cost in the box below. Please put zero if you did not travel by bus, train or taxi
at all or if you did not pay a fare.
Cost of (one-way) fare (£) □□–□□ pence
3. If you and your child travelled by private car, about how many miles did you travel one way? Please
write the number of miles in the box below. Please put zero if you did not travel by private car at all.
Number of miles one way □□□
4. If you and your child travelled by private car and you or your companion had to pay a parking fee, how
much did this cost? Please write the cost in the box below. Please put zero if you did not pay a
parking fee.
Expenditure on parking fee (£) □□–□□ pence
5. When your child was admitted to the hospital, how many nights did he or she spend there? Please
write the number of days in the box below.
Number of nights □□
6. Please circle the number that best describes what you would otherwise have been doing as your main
activity if you had not gone with your child to the hospital.
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Paid work__________________________________________________________________________________1
Housework________________________________________________________________________________2
Child care_________________________________________________________________________________3
Caring for someone else_____________________________________________________________________4
Voluntary work_____________________________________________________________________________5
Leisure activities____________________________________________________________________________6
Other (please specify)________________________________________________________________________7
7. If you take time off from paid work (or business activity if self employed) in order to accompany your
child to the hospital. Please indicate the number of hours you took off from paid work (or business
activity if self employed) in the box below. Please put zero if you did not take time off from paid work
(or business activity if self employed) to accompany your child to the hospital.
Number of hours □□
8. Was there another adult person accompanying you and your child to hospital?
YES
NO
9. While your child was in hospital, approximately how many times did you go to visit your child?
Number of times □□
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Part 2 – Your child’s most recent outpatient visit because of his or her eyes
If in the last 3 months your child did not have an outpatients appointment please go to Part 3.
1. Please circle the number that best describes how you and your child travelled. If you used more than
one form of transport please indicate the way you travelled for the main (longest in terms of distance)
part of your journey.
Bus_______________________________________________________________________________________1
Train_____________________________________________________________________________________2
Taxi______________________________________________________________________________________3
Private car_________________________________________________________________________________4
Hospital car________________________________________________________________________________5
Ambulance________________________________________________________________________________6
Other (please specify)________________________________________________________________________7
2. If you and your child travelled by bus, taxi or train to your child’s outpatients appointment what was the
total cost of the (one-way) journey? Please write the cost in the box below. Please put zero if you did
not travel by bus, train or taxi at all, or if you did not pay a fare.
Cost of (one-way) fare (£) □□–□□ pence
3. If you and your child travelled by private car, about how many miles did you travel one way? Please
write the number of miles in the box below. Please put zero if you did not travel by private car at all.
Number of miles one-way □□□
4. If you and your child travelled by private car and you had to pay a parking fee, how much did this cost?
Please write the cost in the box below. Please put zero if you did not pay a parking fee.
Expenditure on parking fee (£) □□–□□ pence
5. When you and your child visited outpatients, how long did it take to travel there? Please write the
number of hours and minutes in the box below.
Number of hours □□–□□ minutes
6. When you and your child visited outpatients, how long did you spend there? Please write the number
hours and minutes in the box below.
Number of hours □□–□□ minutes
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7. Please circle the number that best describes what you otherwise would have been doing as your main
activity if you had not accompanied your child to the outpatients?
Paid work_________________________________________________________________________________1
Housework________________________________________________________________________________2
Child care_________________________________________________________________________________3
Caring for someone else_____________________________________________________________________4
Voluntary work_____________________________________________________________________________5
Leisure activities____________________________________________________________________________6
Other (please specify)________________________________________________________________________7
8. Was there another adult person accompanying you and your child to the outpatient visit?
YES
NO
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Part 3 – Your child’s most recent GP/nurse appointment because of his or
her eyes
If in the last 3 months your child did not have a GP/nurse appointment, please go to Part 4.
1. Please circle the number that best describes how you and your child travelled to your child’s most recent
GP/nurse appointment. If you used more than one form of transport please indicate the way you
travelled for the main (longest in terms of distance) part of your journey.
Bus______________________________________________________________________________________1
Train_____________________________________________________________________________________2
Taxi______________________________________________________________________________________3
Private car_________________________________________________________________________________4
Bike______________________________________________________________________________________5
Walk_____________________________________________________________________________________6
Other (please specify)_______________________________________________________________________7
2. If you and your child travelled by bus, taxi or train, what was the total cost of the (one-way) fare? Please
write the cost in the box below. Please put zero if you did not travel by bus or taxi or if you did not pay
the fare.
Cost of (one-way) fare (£) □□–□□ pence
3. If you and your child travelled by private car, about how many miles did you travel one-way? Please
write the number of miles in the box below. Please put zero if you did not travel by private car at all.
Number of miles one-way □□□
4. If you and your child travelled by private car and you had to pay a parking fee, how much did this cost?
Please write the cost in the box below. Please put zero if you did not pay for parking.
Expenditure on parking fee (£) □□–□□ pence
5. When you and your child visited the GP/nurse, how long did it take to travel there? Please write the
number of minutes in the box below.
Number of minutes □□□
6. When you and your child visited the GP/nurse, how long did you spend there? Please write the number
minutes in the box below. Please include in your answer the time spent waiting and also the time spent
with the doctors and nurses.
Number of minutes □□□
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7. Please circle the number that best describes what you otherwise would have been doing as your main
activity if you had not accompanied with your child to visit the GP/nurse.
Paid work_________________________________________________________________________________1
Housework________________________________________________________________________________2
Child care_________________________________________________________________________________3
Caring for someone else_____________________________________________________________________4
Voluntary work____________________________________________________________________________5
Leisure activities____________________________________________________________________________6
Other (please specify)_______________________________________________________________________7
8. Was there another adult person accompanying you and your child to the GP/nurse visit?
YES
NO
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Part 4 – Your child’s most recent community optician or optometrist visit
because of his or her eyes
If in the last 3 months your child did not attend a community optician or optometrist, please return the
questionnaire to the interviewer. Thank you!
1. Please circle the number that best describes how you and your child travelled to your child’s most recent
community optician or optometrist appointment. If you used more than one form of transport please
indicate the way you travelled for the main (longest in terms of distance) part of your journey.
Bus_______________________________________________________________________________________1
Train______________________________________________________________________________________2
Taxi_______________________________________________________________________________________3
Private car_________________________________________________________________________________4
Bike_______________________________________________________________________________________5
Walk______________________________________________________________________________________6
Other (please specify)________________________________________________________________________7
2. If you and your child travelled by bus, taxi or train, what was the cost of the (one-way) fare? Please
write the cost in the box below. Please put zero if you did not travel by bus or taxi or if you did not pay
the fare.
Cost of (one-way) fare (£) □□–□□ pence
3. If you and your child travelled by private car, about how many miles did you travel one-way? Please
write the number of miles in the box below. Please put zero if you did not travel by private car at all.
Number of miles one-way □□□
4. If you and your child travelled by private car and you had to pay a parking fee, how much did this cost?
Please write the cost in the box below. Please put zero if you did not pay for parking.
Expenditure on parking fee (£) □□–□□ pence
5. When you and your child visited the community optician or optometrist, how long did it take to travel
there? Please write the number of minutes in the box below.
Number of minutes □□□
6. When you and your child visited the community optician or optometrist, how long did you spend there?
Please write the number minutes in the box below. Please include in your answer the time spent waiting
and also the time spent with the doctors and nurses.
Number of minutes □□□
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7. Please circle the number that best describes what you otherwise would have been doing as your main
activity if you had not accompanied your child to visit community optician or optometrist.
Paid work_________________________________________________________________________________1
Housework________________________________________________________________________________2
Child care_________________________________________________________________________________3
Caring for someone else_____________________________________________________________________4
Voluntary work_____________________________________________________________________________5
Leisure activities____________________________________________________________________________6
Other (please specify)________________________________________________________________________7
8. Was there another adult person accompanying you and your child to the community optician or
optometrist visit?
YES
NO
If you have any comments about this questionnaire or about the Exotropia trial please use this space to
write them:
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Appendix 8 Tables for pilot study
TABLE 22 Sources of collecting resource-use data
Resource use Data collection source
Intervention
No. of times Receiving general anaesthetic CRF
Receiving local anaesthetic
No. of cases Day cases CRF
Inpatient cases
Mean Operation theatre time CRF
Recovery room time
No. NHS travel: Hospital car Participant Costs Questionnaire
Ambulance
Follow-up resource use: secondary care
No. of times Receiving further surgery CRF
Receiving BOTOX® (Allergan) injections
No. of cases Outpatient visits Participant Costs Questionnaire
Inpatients, night
No. of NHS travel Hospital car Participant Costs Questionnaire
Ambulance
Follow-up resource use: primary care
No. of times GP visits Participant Costs Questionnaire
Nurse visits
Optometrist visits
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TABLE 23 Sources of obtaining unit cost data
Unit cost of resource use Data collection source
Intervention costs
Consumables Manufacturers’ price list
Reusable
Per general anaesthetic
Per local anaesthetic
Theatre time per minute PSSRU
Recovery room time per minute
Surgeon per minute
Anaesthetist per minute
Registrar group per minute
Other staff per minute
Associate specialist per minute
Theatre staff per minute
Recovery room staff per minute
Per day case PSSRU
Per inpatient stay per night
Hospital car per journey PSSRU, Participant Costs Questionnaire
Ambulance per journey
Follow-up: secondary care costs
Further surgery Estimate based on the costs of the initial surgery
BOTOX injection Manufacturers’ price list
Inpatient stay per night PSSRU
Outpatient visit
Hospital car per journey PSSRU, Participant Costs Questionnaire
Ambulance per journey
Follow-up: primary care costs
GP visit PSSRU
Nurse visit
Optometrist visit
PSSRU, Personal Social Services Research Unit.
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